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1. Introduction 
1.1. microRNA (miRNA) 
1.1.1. Historical background of miRNA 
MicroRNAs (miRNAs) are a recently discovered class of naturally occurring small RNA 
molecules (~22nt) that regulate specific genes post-transcriptionally. The first reported miRNA, 
lin-4, was cloned from C. elegans in 1993 (Lee et al., 1993; Wightman et al., 1993). This 
remained a singular example until 2000 when a second miRNA, let-7, was discovered (Reinhart 
et al., 2000). Unlike lin-4, the sequence of let-7 was found to be highly conserved in eukaryotic 
genomes (Pasquinelli et al., 2000). It was soon realized that similar sequences were present in 
eukaryotic genomes and that they represent a new class of regulatory RNA molecules, first 
called ‘miRNA’ by Ambros in 2001(Chen and Meister, 2005). 
Since this time, interest in the miRNA-field has exploded resulting in hundreds of miRNAs 
being cloned from a wide range of animals. In human, there have been more and more 
experimentally confirmed miRNAs in the genome. Computational approaches suggest that their 
number is in a thousand (Bentwich et al., 2005; Berezikov and Plasterk, 2005). As of recent, the 
number of annotated human miRNAs is approximately closed to 1600 (Kozomara and Griffiths-
Jones, 2010). 
1.1.2. miRNA biogenesis 
Many miRNAs are phylogenetically highly conserved, 20 to 22 nucleotide non-protein-coding 
RNA molecules that recognize target sequences of imperfect or perfect complementarity in 
cognate messenger RNA (mRNA) and mediate post-transcriptional gene repression by inhibiting 
proteins translation or destabilizing target mRNA transcripts (Monticelli et al., 2005; Shivdasani, 
2006). miRNAs play an important role in cell differentiation and regulation of gene expression 
during development (Fazi et al., 2005), For example, miR193b-365 and miR-133 have been 
reported as essential factors for brown fat differentiation (Sun et al., 2011; Trajkovski et al., 
2012b). miRNAs are believed to fine-regulate a diverse array of biological processes (Shivdasani, 
2006). Their implication in biological processes is ranging from cell proliferation and cell death 
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during development to stress resistance, fat metabolism, insulin secretion and hematopoietic 
differentiation (Monticelli et al., 2005). 
So far, over 1600 miRNAs  have yet been reported in humans and are annotated in the miRNA-
registry (Kozomara and Griffiths-Jones, 2010). Recent evidence suggests that the actual number 
of miRNA is likely to be increased. 
Most human miRNAs are encoded within introns of coding or non-coding messenger-RNA 
(mRNA), whilst others are located intergenically or within exons (Rodriguez et al., 2004). 
miRNA genes are also co-transcribed together with their host gene in some cases (Mraz and 
Pospisilova, 2012). However, as much as 40% of miRNA genes lie in introns of protein coding 
genes, approximately 10% of miRNAs are located within introns of long non-coding RNA 
transcripts and the rest of miRNAs are found in exons of long nonprotein-coding transcripts 
(Rodriguez et al., 2004). miRNAs are transcribed by RNA-polymerase II as 5’-capped 
polyadenylated precursors known as pri-miRNAs (primary miRNAs)  (Lee et al., 2004). 
Approximately more than half of the human miRNAs are encoded in tandems or clusters that are 
co-expressed within single pri-miRNAs, whilst other pri-miRNAs encode a single miRNA 
sequence. Pri-miRNAs are cleaved within the nucleus to form 60-70 nucleotide hairpin 
structures termed pre-miRNA (precursor-miRNA) by the microprocessor complex consisting of 
Drosha and DGCR8 (Gregory et al., 2006). Pre-miRNAs are exported from the nucleus to the 
cytoplasm by exportin-5 in a RAN-GTP-dependent manner. Cytoplasmic pre-miRNAs are then 
further cleaved to form an asymmetric duplex (the miRNA / miRNA*duplex) by Dicer in 
association with TRBP. The mature miRNA strand is incorporated into the translational 
repressor complex: RNA Induced Silencing Complex (RISC) (Figure 1A) (Lund et al., 2004). 
1.1.3. Regulatory function of miRNAs 
The strand with lower stability base pairing at its 5’end preferentially binds to RISC and 
becomes the active mature miRNA (Preall et al., 2006). The RISC-miRNA complex then binds 
to its cognate 3’UTR sequence in the target messenger-RNA initiating translational repression or 
modification (Figure 1A, B). 
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3'UTRCEBP-CDS
UUUUCCGUUUCA--AGCAUU--AA--------GAACACUUUUAAUAAACUU
UUUUCCGUUUCG--AGCAUUAAAGUGAAGACAUU-UUAAUAAACU-
UUUUCCGUUUCG--AGCAUUAAAGUGAAGACAUU-UUAAUAAACU-
Hsa
Mmu
Rno
...................... 450.....................460....................470......................480
5'-
5'-
5'-
-3'
-3'
-3'
UGGGGAUAGUGUUAAUCGUAA-UU -5'3'-mmu-miR-155
miRNA155
8-mer
binding site
5' AAAAA3'
1 453 459 500
 
Figure 1. miRNA biosynthesis: (A) The miRNA is generated from the miRNA gene. With help of RNA 
polymerase 2, the pri-miRNA (500-3000bp) is formed. The enzyme complex Drosha cleaves the pri-
miRNA to the precursor-miRNA (~70bp). During this process, the pre-miRNA is transported outside the 
nucleus into the cytoplasm by Exportin 5 (transporting protein). At the end, the pre-miRNA is cut to the 
mature miRNA by Dicer.  (B) Example for miRNA binding to target mRNAs (ie. On 3’ UTR of C/EBPβ 
mRNA, there is 8-mer binding site for the respective miR-155). Figure 1A is adapted from Velu’s figure 
(Velu et al., 2012). 
 
Introduction 
4 
 
miRNAs perform their function by binding to complementary binding sites  on the target mRNA, 
and thereby regulating mRNA translation or degradation. Because of imperfect binding to the 
3’UTR, many mRNAs can be targeted by one miRNA. Conversely, several different miRNAs 
can bind to and cooperatively control one single mRNA target. Recent studies have predicted 
that over 30% of human genes are putatively regulated by miRNAs (Lewis et al., 2005). 
miRNAs negatively regulate their targets in one of two ways, depending on the degree of 
complementarity between the miRNA and the target mRNA: First, miRNAs binding to their 
mRNA targets with imperfect complementarity blocks target gene expression at the level of 
protein translation. Complementary sites for miRNAs using this mechanism are generally found 
in the 3’UTR of target mRNAs. Second, miRNAs binding with perfect (or nearly perfect) 
complementarity induce target mRNA cleavage. Complementary sites mediating this mechanism 
are usually located in the open reading frame (ORF) of mRNA targets (Figure 2).  
 
                   
Figure 2. The miRNA/ RISC complex is binding to the target mRNA. Binding to sequences within the 
ORF with high homology mediates mRNA degradation (left) whereas low-complementarity binding to 
the target mRNA 3´UTR induces translation inhibition (right). Figure is adapted from (Liu et al., 2008). 
 
1.2. Adipose tissue biology 
There are two different types of adipose tissues in mammals: white adipose tissue (WAT) and 
brown adipose tissue (BAT). BAT cells have a large content of mitochondria and contain less 
lipids in comparison to WAT cells. The major function of BAT and WAT in mammals is about 
energy metabolism. BAT is responsible for energy expenditure, whereas WAT is mainly 
responsible for energy storage (Lowell and Flier, 1997). With regard to  molecular biology, BAT 
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and WAT cells share the expression of many crucial “adipogenic” genes such as CCAAT 
Enhancer Binding Protein family members (C/EBPs), peroxisome proliferator-activated receptor 
gamma (PPARγ), and Fatty-acid Binding Protein 4 (FABP4 or aP2). However, high expression 
of so-called “thermogenic” genes is characteristic for BAT cells. These include uncoupling 
protein 1 (UCP1), peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-
1α), and cell death-inducing DNA fragmentation factor α-like effector A (Cidea) (Zhou et al., 
2003). These genes are essential for the  major function of BAT: energy expenditure for 
thermogenesis (Rosen and MacDougald, 2006). 
1.2.1. Brown adipose tissue (BAT) vs. White adipose tissue (WAT) 
Human brown adipose tissue is mainly located in the supraclavicular region around the shoulders 
and is mainly found in newborns. The thermogenic activity of BAT is necessary to prevent body 
temperature loss after birth and in cold conditions. Importantly, recent studies have shown that 
BAT also exists in adults, and slim persons have higher BAT activity than obese individuals. 
Furthermore, more active BAT is found in females than in males (van Marken Lichtenbelt et al., 
2009). 
White adipose tissue is distributed widely throughout the whole body. There are two major 
classifications of human white adipose tissue: visceral white adipose tissue (vWAT) which is 
mainly surrounding organs, and subcutaneous white adipose tissue (sWAT) which is located 
beneath the skin, such as inguinal white adipose tissue (igWAT). Interestingly igWAT has been 
found to be capable to switch to brown-like adipose tissue (beige adipose tissue) (Petrovic et al., 
2010; Seale et al., 2011). 
These beige adipocytes show increased energy expenditure and expression of thermogenic genes, 
very similar to brown fat. This “browning” mechanism of white fat cells is driven by a number of 
transcriptional regulators and is considered therapeutically interesting with regard to the 
treatment of obesity (Ohno et al., 2012; Seale et al., 2008; Seale et al., 2011; Trajkovski et al., 
2012a; Vegiopoulos et al., 2010). 
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1.2.2. Biogenesis of mesenchymal stem cells and their therapeutic potential  
Stem cells are defined by their ability of self-renewal and potential to differentiate into a variety 
of distinct tissues. There are several different types of stem cells, which can be distinguished by 
their differentiation potential. Embryonic stem cells are called pluripotent, because they can be 
differentiated to all types of cell in vitro, thus it is able to rebuild the whole organism. In contrast, 
adult stem cells have only a limited potency of differentiation and are mostly located in the 
respective organ of their tissue type.    
Mesenchymal Stem Cells (MSCs) are adult multi-potent stem cells that constitute a variety of 
adult mesenchymal tissues (Collet and Des Biens, 1975). MSCs maintain self-renewal ability 
with the potential to differentiated into bone, cartilage, adipose tissues, stroma, connective tissue, 
muscle (Pelled et al., 2002). MSCs can be isolated from bone marrow, adipose tissues or other 
organs and expanded to be cultured in vitro. MSCs play a crucial role in bone physiology and 
hematopoiesis (Sacchetti et al., 2007), and in part participate in the pathophysiology related to 
bone diseases. Furthermore, MSCs are the progenitors that give rise to adipose tissues. These 
features have made MSCs be  a good candidate for the development of therapeutic modalities 
aiming to regenerate mesenchymal tissues (Pelled et al., 2002). Important methods utilizing 
MSCs are gene therapy or cell therapy approaches. Both exploit the current knowledge in 
molecular biology and biomaterial science in order to direct MSCs to differentiate in vivo to 
desired lineages and tissues, for example adipose tissues. With the powerful tools of gene 
therapy on hands, MSCs can be effectively transduced with viral vectors containing a therapeutic 
gene, as well as with complementary DNA (cDNA) for specific proteins, whose expression is 
therapeutically relevant for a patient (Bobis et al., 2006). Better understanding of the molecular 
mechanism directing the differentiation of MSCs will allow us to properly control MSCs both in 
vivo and ex vivo to allow the regeneration of complex tissues and organs (Saraf and Mikos, 2006).  
In vitro studies, MSCs are artificially induced to differentiate into osteocytes, chondrocytes and 
adipocytes, such as bone marrow-MSCs (Figure 3). 
Introduction 
7 
 
                                   
Figure 3. Lineage tree of mesenchymal cell. Source of image: website: http://articell.cz.  
1.2.3. Adipogenesis of mesenchymal stem cells   
MSCs can be in vitro differentiated to adipocytes by stimulation with certain compounds in 
various combinations (Jennissen et al., 2013). The MSCs used in this study were derived from 
brown adipose tissue (BAT-MSCs) or inguinal white adipose tissue (igWAT-MSCs). When 
these cells are stimulated with a cocktail of hormones, these MSCs differentiate into mature BAT 
or WAT cells respectively (Haas et al., 2009).  
CCAAT Enhancer Binding Protein family (C/EBPs) and the hormone receptor peroxisome 
proliferator-activated receptor gamma (PPARγ) have been shown to play a crucial role in 
adipogenesis. PPARγ is frequently increased in primary mesenchymal stem cells that are 
differentiating to fat cells. The transcription factors which have been implicated in fat cell 
development in the C/EBP family are CCAAT Enhancer Binding Protein alpha (C/EBPα), 
CCAAT Enhancer Binding Protein delta (C/EBPδ), and CCAAT Enhancer Binding Protein beta 
(C/EBPβ) (Wu et al., 1999). C/EBPδ and β induce the expression of PPARγ. Ectopic expression 
of C/EBPδ and β leads to the induction of PPARγ This induction is a direct transcriptional effect, 
as the PPARγ promoter possesses C/EBP transcription factor binding sites (Shi et al., 2003). 
PPARγ and C/EBPs are able to induce each other's expression in a positive feedback loop that 
promotes and maintains the differentiated state of adipocytes (Wu et al., 1999).  
However, there is evidence that C/EBPβ is more crucial in BAT than in WAT cell differentiation 
(Seale et al., 2008; Seale et al., 2011). Deletion of C/EBPβ (C/EBPβ-/-) in mice induces a 
stronger deregulation development of brown adipose tissue, but not white adipose tissue (Tanaka 
et al., 1997). In contrast, C/EBPα-/- embryos have reduced levels of PPARγ (Wu et al., 1999) and 
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PPARγ-/- embryos die after 10 days (E9.5-E10) (Rosen et al., 2002). These phenotypes clearly 
underline the importance of the complex interplay of transcription factors in tissue development 
and especially in adipose tissue. 
 
1.3. Brown adipose tissue (BAT) 
1.3.1. BAT function in mammals 
BAT is an organ unique to higher mammals that has developed parallel to endo-/homeothermy 
(Gesta et al., 2007). BAT is important for the thermoregulation especially during the neonatal 
period. The activated tissue dissipates energy in form of heat and thereby protects newborn 
mammals against low temperatures (e.g. after birth). 
BAT has been shown to be present and functional in adult humans either. Recent PET (positron 
emission tomography) studies have clearly demonstrated that  BAT depots can be stimulated/ 
metabolically activated by cold exposure in humans (Cypess et al., 2009; Nedergaard et al., 2007; 
Saito et al., 2009; van Marken Lichtenbelt et al., 2009; Virtanen et al., 2009). Cold-activated 
BAT depots can be observed around the supraclavicular region and along the spine (Figure 4). 
Interestingly, these PET studies also revealed that BAT activity is significantly reduced in 
overweight or obese subjects (van Marken Lichtenbelt et al., 2009). These findings together with 
the large capacity of BAT to disperse energy, suggests that increasing BAT abundance and 
activity could counteract obesity.                               
 
                                            
Figure 4. Cold induced brown fat tissue activation in adult human. The same patient was scanned by 
FDG-PET twice are shown. Cold condition (left) and RT condition (right). Figure is from (van Marken 
Lichtenbelt et al., 2009). 
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1.3.2. BAT development 
Brown adipocyte development is much closer related to skeletal muscle than white adipocyte 
development (Figure 5). A certain transcription factor, myogenic factor 5 (Myf5), is an 
especially important regulator for linage determination of brown precursors. Myf5 expressing 
mesenchymal stem cells (Myf-positive cells) are progenitor stem cells of brown adipocytes and 
skeletal muscle. In contrast, Myf-negative adipoblast cells are white adipocyte progenitors. Both 
bone morphogenetic protein (BMP7) and PRD1-BF1-RIZ1 homologous domain containing 16 
(PRDM16) can stimulate Myf5 expressing cells to differentiate to brown adipocytes, but inhibit 
skeletal muscle differentiation (Tseng et al., 2008). PRDM16 has been shown to be a major 
switch between brown adipocyte and skeletal muscle developments (Seale et al., 2008), and the 
transcription factor plays a key role at the early stage of brown adipocyte development. 
The transcription factor C/EBPβ is an important co-factor for PRDM16. It can bind to PRDM16 
and forms a protein-protein transcriptional complex (Kajimura et al., 2009). This complex drives 
Myf5 expressing cells towards brown adipocytes, but not skeletal muscle and plays a critical role 
in brown fat differentiation. However, in white fat differentiation there is no such pathway 
known. It implies that the transcription factor C/EBPβ is one of key factors in adipogenic 
differentiation, but more importantly in the early stage of brown adipogenic differentiation 
(Figure 5). 
                         
Figure 5. Brown fat differentiation requires both C/EBPβ and PRDM16. Figure is adapted from (Seale et 
al., 2008). 
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Importantly, mature brown adipocytes are rich in mitochondria and express high levels of 
uncoupling protein-1 (UCP-1). UCP-1 uncouples the mitochondrial respiratory chain and, 
thereby, leads to the energy dissipation in form of heat (thermogenesis) – the functional hallmark 
of BAT. 
Furthermore, in the past, mature brown and white adipocytes had been shown to trans-
differentiate to each other. This process is driven by hormones like catecholamines, β-agonists, 
as well as by cold exposure in vivo (Figure 6). This process is so-called "browning”. 
Nevertheless, beige adipocyte still could be regarded as functional brown adipocyte (Nedergaard 
and Cannon, 2013) (Figure 6).   
                                          
Figure 6. There are two types of adipocyte, brown adipocytes and white adipocytes. Apart from these two 
types, there is another type of adipocyte - beige adipocytes which are derived from white adipocytes, but 
has a certain function of brown adipocyte. The figure is adapted from (Nedergaard and Cannon, 2013). 
 
1.4. miRNAs in brown fat (BAT) differentiation  
As previously described, miRNAs have a very important function in biological cellular 
development by post-transcriptional gene regulation. They have been shown to be especially 
relevant as regulars of transcription factors in developmental processes (Krutzfeldt et al., 2006; 
Krutzfeldt et al., 2011). There are many crucial transcriptional regulators during BAT or WAT 
differentiation, such as C/EBPs, PPARγ, Myf-5, and PRDM16. Recent research showed that 
miR-193b-365 is essential for brown fat differentiation, which revealed an very important role of 
miRNAs in brown fat differentiation (Sun et al., 2011). In 2012, miR-196a has been found to 
promote appearance of beige adipocytes in WAT. This study showed the capacity of miRNAs to 
regulate the “ browning” processing in WAT cells (Mori et al., 2012). Moreover, PRDM16, has 
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been found to directly regulated by miR-133 (Trajkovski et al., 2012b). In this term, miRNAs 
may become an effective factor to turn on the beneficial thermogenic functions of BAT or switch 
the “unhealthy-white fat (WAT)” to energy dissipating “healthy brown-like fat (beige fat)” in 
order to treat diabetes and obesity. Thus, the regulatory potential of miRNAs in brown or beige 
fat differentiation becomes more and more therapeutically relevant. 
 
1.5. TGFβ1-Smad signaling pathway in adipogenesis 
Transforming growth factor beta (TGF-β) regulates many biological processes, and aberrant 
TGF-β signaling is implicated in tumor development (Amanda et al., 2010). Moreover, 
TGFβ1/Smad3 signaling is involved in adipogenesis: TGFβ1 inhibits adipocyte differentiation 
via Smad3 interaction with C/EBPs (Choy and Derynck, 2003), This indicates that there is some 
kind of interaction existing between TGFβ and the C/EBP transcription factor family in 
adipogenesis. Smad3 also has been shown to regulate BAT-specific genes, like PGC-1α and 
PRDM16, which co-operate with C/EBPβ in the brown adipocyte differentiation (Seale et al., 
2008). Deletion of Smad3 causes white adipocytes to trans-differentiate to beige adipocytes 
(Yadav et al., 2011; Yadav and Rane, 2012). TGFβ1 has been shown to induce the expression of 
several miRNAs, among them miR-155 in epithelial cells. Smad4 is a co-factor with other Smads 
in TGFβ1-signaling pathway. It is also called co-Smad and works together with such as Smad3, 
Smad5, by forming heteromers. TGFβ1 cannot induce miR-155 expression without Smad4 
activity in epithelial cells (Kong et al., 2008). This indicates that TGFβ1 may also induce 
miR-155 expression via the TGFβ1/Smad4 signaling pathway in adipocytes; thereby 
TGFβ1/Smad4/miR-155 pathway may be involved in regulation of adipogenesis (Figure 7). 
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 Figure 7. miR-155 expression is activated by TGFβ / Smads signaling in epithelial cell.   
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1.6. Aim of the PhD thesis  
miRNAs are small non-coding RNAs that can regulate many cellular  processes via targeting e.g. 
signal transduction proteins or transcription factors. To date, not much is known about the 
regulatory function of miRNAs in brown adipose tissue (BAT) – the major site of energy 
expenditure in form of heat (thermogenesis) in mammals. 
Therefore, the aim of this thesis is to identifiy miRNAs that are differentially regulated during 
BAT differentiation and that play a role in BAT development and function. The following main 
questions are addressed: 
 Which miRNAs are significantly up- or down- regulated during brown fat differentiation? 
 Which signaling pathways regulate these miRNAs?  
 Does over-expression or knock-down of these miRNAs influence brown fat 
differentiation in vitro? 
 What are the major mRNA targets of the identified miRNA in BAT cells and what is the 
targets´ function in brown fat differentiation? 
 Does over-expression or deletion of this miRNA affect brown fat differentiation and 
function in in vivo models? 
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2. Materials and Methods 
2.1. Materials 
2.1.1. Reagents 
Acetic acid Sigma-Aldrich 
ADP Sigma-Aldrich 
ammonium persulfate (APS) Merck 
Agarose PeqLab 
Ampicillin Roth 
ATP Sigma-Aldrich 
BSA Roth 
BSA (essential fatty acid free) Sigma-Aldrich 
Bromphenol blue Roth 
β-mercaptoethanol Sigma-Aldrich 
CaCl2 Roth 
Chloroform Roth 
Complete® EDTA-free Roche 
Coomassie brilliant blue G-250 Merck 
Digitonin Sigma-Aldrich 
Desoxy-cholic acid-Na Sigma-Aldrich 
Dithiothreitol Sigma-Aldrich 
ECL reagent Amersham Biosciences 
EGTA Sigma-Aldrich 
Ethanol Roth 
Ethidium bromide Carl Roth GmbH 
Ethylendiamintetraacetate (EDTA) Sigma-Aldrich 
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Eosin G Merck 
Ficoll Typ 400 Sigma-Aldrich 
Free Glycerol Reagent Sigma-Aldrich 
Glucose SERAG 
Glutamate Sigma-Aldrich 
Glycerol Standard Solution Sigma-Aldrich 
HCl Roth 
Hydrogen peroxide Roth 
HEPES Sigma-Aldrich 
Imidazole Sigma-Aldrich 
IMMU-MOUNT 
Thermo 
Scientific,Waltham 
Isopropyl alcohol (99%) Roth 
Kanamycin Roth 
KCl Roth 
KH2PO4 Roth 
LightCycler® SYBR Green I Master mix Roche 
L-(-)-Norepinephrine bitartate salt monohydrate (NE) Sigma-Aldrich 
Malate Sigma-Aldrich 
Mannitol Sigma-Aldrich 
Methanol Roth 
MgCl2 Roth 
Mayers hemalaun Merck 
4-Morpholineethanesulfonic acid Sigma-Aldrich 
NaCl Roth 
NaF Roth 
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Na2HPO4 Roth 
Na3VO4 Sigma-Aldrich 
Na-Citrate Roth 
NP-40 Roth 
Oil RedO Sigma-Aldrich 
Oligomycin Sigma-Aldrich 
Paraffin Roth 
Paraformaldehyde Sigma-Aldrich 
PeqGOLD TriFast® Peqlab 
Phosphoric acid Sigma-Aldrich 
Precision plus All Blue Standard BioRad 
Protease inhibitor cocktail, Complete® EDTA-free Roche 
Proteinase K Roche 
Restriction enzymes New England Biolabs 
Roti®-Histokitt Carl Roth GmbH 
Roti® Phenol/C/I Carl Roth GmbH 
Rotiphorese®Gel 30 Carl Roth GmbH 
Sodium ascorbate Sigma-Aldrich 
SDS  Sigma-Aldrich 
Succinate Sigma-Aldrich 
Skimmed milk Sigma-Aldrich 
Taurine Roth 
T4 DNA ligase Invitrogen 
Tween 20 Sigma-Aldrich 
TEMED Sigma-Aldrich 
Triglyceride Reagent Sigma-Aldrich 
Materials and Methods 
17 
 
Triton X-100 VWR 
Xylencyanol FF Sigma-Aldrich 
Xylol Sigma-Aldrich 
 
2.1.2. Cell culture 
Collagenase II Worthington, Lakewood 
Dexamethason Sigma-Aldrich 
DMSO Roth 
DMEM Gibco 
DMEM, liquid (4.5 g/L D-glucose) Gibco 
Fetal bovine serum (FBS) Biochrom AG 
Insulin Sigma-Aldrich 
Isobutylmethylxanthine (IBMX) Sigma-Aldrich 
Lipofectamine™ 2000 Invitrogen 
Penicillin, Streptomycin (P/S) Biochrom AG 
Triiodothyronine-Na Sigma-Aldrich 
Trypan blue 0.4% solution Sigma-Aldrich 
Trypsin-EDTA 0.05% Invitrogen 
 
2.1.3. Lab wares 
Cell scraper Labomedic 
Chemiluminescence films, Hyperfilm® Amersham Biosciences 
Cryogenic vials Sarstedt 
100 mm dish Sarstedt 
15 ml / 50 ml Falcon tube Sarstedt 
Microscope Cover Glasses Marienfeld GmbH 
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5 ml / 10 ml / 25 ml pipette Sarstedt 
6-well / 12-well plate Sarstedt 
PVDF membranes, Immobilon®P 0.45µm Millipore 
Sterile filter 0.22 µm VWR 
 
2.1.4. Equipments 
Autoclave, Varioklav 135 T Faust 
Casting platforms EmbiTech 
Centrifuge, Biofuge Primo Heraeus 
Centrifuge, 5415R Eppendorf 
Centrifuge, Sigma 8k with 12510-H rotor Sartorius 
DatLab Version 4.2.0.73 Software Oroborus Instruments 
Electrophoresis/blotting system, Mini Trans Blot System BioRad 
Electrophoresis chamber Peqlab 
Film processor, CP100 Agfa 
Fluorescence microscope, LEICA DMIL4000 B Leica 
Incubator, Certomat IS Sartorius 
Incubator, HeraCell 150 Heraeus 
Laminar air flow, HeraSafe Heraeus 
Leica Application Suite V3 
Leica Microsystems 
GmbH 
Luminometer, Lumat LB 9507 EG&G BERTHOLD 
Micro plate reader, SUNRISE-BASIC TECAN Tecan 
Microsystems GmbH, WetzlarCamera, LEICA DFC425C Leica 
Microsystems GmbH, WetzlarAxioCam camera and 
AxioVision software 
Zeiss 
Microwave Severin 
Materials and Methods 
19 
 
Neubauer counting chamber Labomedic 
Photometer, Biophotometer Eppendorf 
Power supply, Consort E835 Peqlab 
QuantityOne® Software BioRad 
Oxygraph-2k Oroborus Instruments 
Real-time PCR machine, StepOnePlus™ Real-Time PCR 
System  
Applied Biosystems 
Thermocycler, T1 Biometra 
Thermomixer, 5350 Eppendorf 
UV light transilluminator, GelDoc®XR BioRad 
WetzlarMicrotome, HM335E Microm 
 
2. 2. Methods 
2.2.1. Animals 
2.2.1.1. Animal breeding 
Transgenic mice used in this study were established, maintained and bred in the animal facility 
of H.E.T (House of Experimental Therapy Centre) at University of Bonn in Germany. To obtain 
miR-155 transgenic mice, a PGK or UCP1 promoter driven eGFP mRNA/pre-miR-155 cassette 
was cloned into a lentiviral vector. High titer virus was used to transduce preimplantation 
embryos as described previously (Pfeifer et al., 2002). Genotypes were assessed by PCR 
detection of the eGFP-cassette in genomic DNA. miR-155 knock-out mice (Thai et al., 2007) 
were purchased from Jackson Laboratory in USA. All the animals were maintained on a daily 
cycle of 12 h light (06:00 to 18:00) and 12 h darkness (18:00 to 06:00) at steady room 
temperature around 24°C and were allowed free access to standard rodent diet and water. Mice 
were separated by sex and marked with ear tags at the age of 4 weeks after birth. Mice at young 
age (1 or 2 weeks old) which were taken to be sacrificed had been marked by toes cut. 
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2.2.1.2. Cold exposure experiments  
The analysis of the influence of miR-155 deletion on BAT in vivo was performed using 
littermates’ male mice at the age of 12 – 16 weeks. Mice were fasted for 3 h at 24°C (room 
temperature) with free access to water but without access to chow to exclude the possibility of 
different feeding states. Afterwards, mice were exposed to 4°C (acute cold exposure), for 4 h 
without access to chow. Subsequently, mice were sacrificed and dissected. 
2.2.1.3. Mouse body surface or core temperature 
The body temperature was measured as ability of BAT activity in vivo. The infrared camera was 
used to measure the body surface temperature of all mice pups at age of 1 week. In Cold 
exposure experiments, 12 to 16 weeks old littermates’ male mice were shaved to expose back 
without furs. The rectal temp-meter was used to measure body core temperature of mice at age of 
10 to 16 week. 
2.2.1.4. Metabolic cage measurement (TSE) 
Male mice at 16 weeks of age were kept in TSE cages over weekend before starting 
measurement. Fat mass and lean mass of the mice were measured by NWR minispec analyzer 
instrument (LF50H, Bruker), and also body weights were weighted before starting TSE data 
recording at measuring day. TSE cages temperature were set to 24°C at first measuring day, 
30°C at second day, and then 4°C for 4 h at third day. Food intake, oxygen consumption and 
carbon dioxide emission, etc. were recorded by TSE sensors and output data by the system. 
2.2.1.5. Measurement of lipolysis in brown adipose tissue (BAT) 
To measure the basal lipolytic activity in BAT from cold stimulated wild type or miR-155
-/-
 mice, 
BAT tissues were isolated from the animals immediately after cold exposure. Half a lobe of BAT 
was taken and shredded with scissors (Everhards, ES19) completely for the assay. The 
homogeneous mixture was incubated in lipolysis medium which consist of DMEM, liquid (4.5 
g/L D-glucose) (Gibco) supplemented with 1% P/S and 2% essential fatty acid free BSA (Sigma-
Aldrich). The first 50μl of medium were taken after half hour incubation at 37°C and 5% CO2, 
then after 2 h incubation at same condition, again 50μl of medium were taken. Then, the lipolytic 
activity was measured by quantifying the glycerol concentration. 750 µl of the Free Glycerol 
Reagent (Sigma) were added to the 50 µl of medium, the samples were incubated at 37°C for 5 
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minutes afterwards the absorbance was measured at 540 nm (SUNRISE). A glycerol standard 
(Glycerol Standard Solution; Sigma-Aldrich) was used to calculate glycerol concentrations. The 
glycerol release was normalized to the protein content of the samples. Therefore, the remaining 
medium was removed from the cells, total cell lysates were prepared and protein concentration 
was determined as described in 2.3.1. The finial lipolysis values from BAT of mice were 
calculated by 2 h value subtracting to half an hour value. 
2.2.1.6. Preparation of paraffin sections 
Interscapular BAT and inguinal WAT were fixed overnight in PFA (4% in PBS pH 7.4) at 4°C. 
Afterwards tissue samples were dehydrated by successive incubations in ethanol with ascending 
concentrations (from 50%, 70%, 96% to 100%) for 1 h each at room temperature (RT). 
Subsequently, samples were incubated 3 times in xylol for 10 minutes each at RT and 3 times in 
paraffin for 1 h each at 60°C. Tissue samples were embedded in fluid paraffin (60°C) and cooled 
down to RT. Paraffin blocks were then stored at RT. Sections with 4-5 µm thickness of tissue 
samples were cut using a microtome (Microm).  
2.2.1.7. Hematoxylin/Eosin (H/E) staining 
H/E staining was performed at RT. Paraffin sections were incubated separately for 2 minutes 
each in xylol (deparaffinization), ethanol with descending concentrations (from 100%, 96%, 70%, 
to 50%) and PBS (rehydration). Afterwards, slides were treated with hematoxylin (Mayers 
hemalaun) for 1 minute, washed shortly with water, and then stained with eosin for 1 minute, 
followed by being washed shortly again with water. Sections were dehydrated separately for 2 
minutes each in ethanol with ascending concentrations (from 50%, 70%, 96%, to 100%) and 
xylol. Finally, tissue samples were mounted in Roti®-Histokit mounting medium. Images were 
taken using a LEICA DMI4000 B microscope (Leica Microsystems GmbH) or Zeiss AxioVision 
microscope. 
2.2.1.8. Immunocytological staining of UCP1 on inguinal white adipose tissue sections 
Immunocytological staining of UCP1 on inguinal white adipose tissue was carried out on 5µm 
paraffin sections. The sections were incubated at 37°C overnight or 42°C for 2 h, then dewaxed 
and rehydrated as described before (2.2.1.6). Antigen retrieval of sections were carried out by 
warming the sections up to 75°C-80°C in 10mM Na-Citrat buffer (pH 6.0) for 20min. 
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Afterwards, the sections were washed 3 times with H2O for 5 min each and incubated in 3% 
H2O2 for 10 min. Tissue sections were blocked with 2.5% goat serum in PBS-T for 1 h at RT and 
incubated overnight with the anti-UCP1 (Abcam, ab10983) antibody which is diluted 1:500 in 
0.25% goat serum (in PBS-T) at 4°C. After 3 times washing in PBS-T for 5min, the secondary 
antibody (anti-rabbit HRP, Santa Cruz) were applied 1:200 in 0.25% goat serum (in PBS-T) for 1 
h at RT. Afterwards the slides were washed 3 times again with PBS-T, dehydrated in ethanol 
with ascending concentrations as described before (2.1.5) and counter-stained with Hematoxylin 
for 3-5min. Finally, sections were mounted in IMMU-MOUNT mounting medium (Thermo 
Scientific). 
 
2.2.2. Cell culture 
2.2.2.1. Isolation of primary BAT-MSCs 
BAT-MSCs were isolated from interscapular brown fat of newborn littermatched wild type and 
miR155
-/-
 mice. The interscapular BAT was resected and transferred to collagenase digestion 
buffer (123 mM NaCl, 5 mM KCl, 1.3 mM CaCl2, 5 mM Glucose, 100 mM HEPES, adjusted to 
pH 7.4, freshly added 1.5% BSA and 0.2% Collagenase II). After incubation in a shaking water 
bath for 30 min at 37°C, tissue remnants were removed by filtration through a 100 µm nylon 
mesh (Millipore). Afterwards the cell suspension was placed on ice for 30 min. The resulting 
infranatant, which contained the MSC fraction, was filtered through a 30 µm nylon mesh 
(Millipore) and centrifuged at 700 g for 10 min. The cell pellet was resuspended in dissection 
medium (DMEM Glutamax I + 4500 mg/l Glucose supplemented with 10 % FBS, 1 % P/S, 4 nM 
insulin, 4 nM Triiodothyronine-Na, 10 mM HEPES and 25 µg/ml sodium ascorbate). Cells were 
counted with trypan blue (1:1) (Sigma-Aldrich) in a Neubauer counting chamber (Labomedic) 
and 5.7 x 10
5
 cells per well were seeded on 6-well plates and incubated in a humidified incubator 
with 5 % CO2 at 37 °C.  
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Figure 8.1.Isolation scheme of BAT-MSCs from interscapular BAT of newborn mice. BAT-MSCs were 
isolated from interscapular BAT of newborn wt or miR155
-/-
 littermates. The BAT tissue was collagenase 
digested; BAT-MSCs (BAT preadipocytes) were separated from mature brown adipocytes by 
centrifugation and seeded on 6-well plates. 
2.2.2.2. Immortalization of primary BAT-MSCs 
Primary BAT-MSCs at p0 (passage 0) were immortalized 24 h after isolation by infection 
(2.2.2.6) with lentivirus expressing the Simian Virus 40 (SV40) large T-antigen under control of 
the phosphoglycerate kinase (PGK) promoter. Immortalized cells were expanded in Dulbecco’s 
modified Eagle’s medium (DMEM) growth medium (Glutamax I + 4500 mg/l Glucose without 
pyruvate, Gibco) supplemented with 10% fetal bovine serum (FBS) and 1% 
penicillin/streptomycin (P/S) at 37°C and 5% CO2 and were not used beyond p5 (passage 5). 
2.2.2.3. Isolation of WAT stromal cells 
WAT-MSCs/stromal cells were isolated from inguinal and gonadal white fat of 8-12 weeks old 
mice of newborn litter-matched wild type or miR155
-/-
 mice. 1g white fat collected from 4 mice 
is always required for the isolation. The inguinal WAT was shredded with scissors (Everhards, 
ES19) completely and transferred to 7 ml WAT collagenase digestion buffer (1.5 mg/ml 
collagenase II and 0.5% BSA in DMEM). After incubation in a shaking water bath for 30-45 min 
at 37°C, same volume of WAT growth medium (DMEM GlutaMAX™ I + 4500 mg/l glucose 
with pyruvate, supplemented with 10% FBS and 1% P/S) was added and incubated at RT for 10 
min. The floating adipocyte fraction was removed by taking off the upper phase (about 1 ml). 
Afterwards, the cells were centrifuged at 200 g for 10 min and the pellet was resuspended in 2 ml 
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WAT growth medium. Then the suspension was filtered through a 100 µm nylon mesh 
(Millipore). Cells were counted and 2 x 10
5
 cells per well were seeded on 6-well plates and 
incubated in a humidified incubator with 5 % CO2 at 37 °C. On the next day, cells were washed 
2-3 times with growth medium to remove dead cells, tissue remnants and mature fat cells. 
 
 
Figure 8.2.Isolation scheme of WAT-MSCs from inguinal WAT of adult mice. WAT-MSCs were 
isolated from inguinal WAT of newborn wt or miR155
-/-
 littermates. The WAT tissue was collagenase 
digested; WAT-MSCs (igWAT preadipocytes) were separated from mature white adipocytes (igWAT) 
and seeded on flask or 6-well plates. 
2.2.2.4. Cultivation and storage of immortalized BAT-MSCs and WAT-MSCs 
The cells were always cultured in a humidified incubator with 5 % CO2 at 37 °C and subcultured 
when they were confluent. In order to detach cells from the well plate, cells were washed in 
prewarmed PBS (37°C) and detached by incubation with trypsin-EDTA (Invitrogen) for 
approximately 5 minutes at 37°C. Detached cells were collected and resuspended in growth 
medium. An appropriate number of cells were seeded on new dishes for further culture. 
To store cells for longer periods of time, cells were trypsinized and resuspended in prewarmed 
(37°C) growth medium. Cell suspensions were centrifuged for 5 minutes at 160 g. The pellets 
were resuspended in growth medium, mixed with freezing medium in a ratio of 1:1 to achieve a 
final dimethyl sulfoxide (DMSO) concentration of 10% and transferred to cryogenic vials 
(Sarstedt). Cryogenic vials were incubated on ice for 15 minutes and were finally stored at -80°C. 
After 24 h, cryo-cultures were transferred to liquid nitrogen (-196°C). 
In order to thaw cryo-preserved cells, cryo-vial was quickly placed in a water bath at 37°C for 30 
seconds. Afterwards cells were transferred to prewarmed (37°C) growth medium, and 
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centrifuged for 5 minutes at 1000 rpm. The cell pellet was resuspended in growth medium and 
seeded on well plates. 
2.2.2.5. Adipogenic differentiation of immortalized BAT-MSCs and WAT-MSCs 
To differentiate immortalized BAT-MSCs into mature brown adipocytes, 1.5 x 10
5
 cells/well 
were seeded on 6-well plates or 0.9 x 10
5
 cells/well on 12-well plates (day -4) in growth medium 
and after 48 h the medium was exchanged with differentiation medium containing additionally 
20 nM insulin, and 1 nM T3 (triiodothyronine) (day -2) for 48 h. Adipogenesis was induced by 
treating confluent cultures (day 0) with induction medium (IM) which is supplemented with 20 
nM insulin, 1 nM T3, 0.5 mM isobutylmethylxanthine (IBMX), and 1 µM dexamethasone (Dexa) 
for 48 h. After this induction phase cells were changed back to differentiation medium (day 2), 
which was replenished every second day until day 7 or 8 when the cells had differentiated into 
brown adipocytes (Haas et al., 2009; Jennissen et al., 2013). 
                 
Figure 9.1.BAT-MSCs (BAT preadipocytes) were differentiated by following from the protocol 
(Jennissen et al., 2013) 
 
For WAT in vitro differentiation, fully confluent cells were kept in growth medium for 2 days, 
and then treated with IM supplemented with 1µg/ml insulin, 1nM T3, 0.25µM dexamethason, 
0.5mM IBMX, 1µM rosiglitazone, and ABP (50µg/ml L-Ascorbat, 1µM Biotin, and 17mM 
Panthothenat). After 6 days, the cells were kept in medium supplemented with 1µg/ml insulin, 
1nM T3, and ABP for another 4 to 5 days. Medium was exchanged every 2 days. 
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Figure 9.2.WAT-MSCs (WAT preadipocytes) were differentiated by following from the protocol 
(Jennissen et al., 2013) 
2.2.2.6. Infection of cells with lentiviral vectors 
For infection, 1.5 x 10
5
 cells / well were seeded in a 6-well plate. When attached, cells were 
infected with 200 ng RTase of the virus (corresponding to physical titer of the virus) in 800 µl 
growth medium. The next day, the medium was exchanged with either fresh growth medium and 
cells were incubated overnight. Afterwards, the infected cells were subjected to further 
experiments. 
2.2.2.7. Oil RedO staining of differentiated adipocytes 
Oil RedO is a dye used for staining of lipids in tissues and cells. Lipid droplets, stained by 
accumulated Oil RedO, appear in a red color. 
Differentiated brown adipocytes (day 7/8) were washed with PBS, fixed in 4% PFA in PBS for 
15 minutes at RT and washed again with PBS for 3 times. Afterwards, the cells were incubated 
with Oil RedO working solution for 4 h at RT and were washed 3 times with PBS. 
5mg/ml Oil RedO stock solution (Sigma-Aldrich) was prepared by dissolving 0.5% Oil RedO 
overnight in 99% isopropyl alcohol with a magnetic stir bar at RT. 3mg/ml Oil RedO working 
solution was then prepared by dissolving 40% of stock solution in H2O one day before use and 
filtering through a paper filter before use. 
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2.2.2.8. Quantification of triglyceride (TG) accumulation in differentiated brown 
adipocytes 
TGs are esters of fatty acids and glycerol. To determine TG accumulation in differentiated brown 
adipocytes, an assay was performed based on coupled enzyme reactions resulting in an increase 
in the absorbance at 540 nm that is directly proportional to the glycerol concentration. Therefore, 
Free Glycerol Reagent (Sigma-Aldrich, F-6428) and Triglyceride Reagent (Sigma-Aldrich, T-
2449) were used according to the manufacturer’s instructions. In brief, differentiated adipocytes 
(day 7/8) grown in 6-well plates were washed with PBS, 200 µl TG-Tx-lysis buffer (150 mM 
NaCl, 10 mM Tris/HCl pH 8.0, 0.05% Triton-X 100, freshly added 40 µl/ml Complete®  
protease inhibitor cocktail) were added and cells were immediately frozen at -80°C. After 
thawing on ice, cells were resuspended and centrifuged for 10 minutes at 15000 g at 4°C. 
Afterwards 2 µl of the supernatant were used for protein content determination applying the 
Bradford method. The remaining part of the sample was resuspended, added to 1 ml of the TG 
assay reagent (80% Free Glycerol Reagent and 20% Triglyceride Reagent), incubated at 37°C 
for 5 minutes and centrifuged for 2 minutes at 15000 g at RT. Afterwards the absorbance was 
measured at 540 nm. A glycerol standard (Glycerol Standard Solution; Sigma-Aldrich) was used 
to calculate glycerol concentrations according to the manufacturer’s instructions. 
2.2.2.9. Luciferase reporter assay 
Luciferases are commonly used as reporters to assess the activity of promoters in cells which are 
transfected with constructs containing the luciferase gene under control of the promoter of 
interest. In the luciferase reaction, light is emitted when enzymes act on the appropriate luciferin 
substrate.  
HIB-1B brown adipose cells, kindly provided by Prof. M. Klingenspor (Technical University 
Munich, Germany) were transiently co-transfected with firefly and Renilla luciferase expression 
vectors at a ratio of 1:1 using Lipofectamine 2000 (Invitrogen) according to the manufacturer’s 
instructions on day -2. Luciferase reporter assays were accomplished on day 0 or day 2 using the 
Dual-Luciferase® Reporter Assay System (Promega) according to the assay protocol. In these 
assays the activities of firefly and Renilla luciferases are measured sequentially from a single 
sample by adding different substrates. Cell lysates were prepared following the instructions for 
passive lysis. The activity of the firefly luciferase was normalized to the corresponding Renilla 
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activity value for each sample. pGL3-BIC/miR-155 promoter assays were normalized to Renilla 
luciferase activity from the co-transfected pRL-TK vector (Promega). 
2.2.2.10. Proliferation assay 
Cell number was determined using the PrestoBlue Cell Viability Reagent (Invitrogen) according 
to manufacturer´s instructions. 
 
2.2.3. Protein analysis 
2.2.3.1. Preparation of total protein lysates from adherent cells and tissues 
For the extraction of total proteins, cells were washed once in 4°C cold PBS and scraped in 100-
200 µl of 4°C cold RIPA-lysis buffer (10mM Tris/HCl pH7.4, 150 mM NaCl, 1% NP-40, 1% 
Desoxy-cholic acid-Na, 0.1% SDS, 40 µl/ml Complete® EDTA-free, 10 mM NaF, 1 mM 
Na3VO4). Tissues were lysed in 500 µl of ice cold RIPA-lysis buffer and disrupted using an 
Ultra-turrax® (IKA). Lysates were centrifuged at 15000 g for 10 minutes at 4°C, and the 
supernatant was transferred into a new tube. The protein concentration of the supernatant was 
determined using the Bradford protein assay. After adjusting the protein concentration, the 
appropriate amount of 3 x Laemmli buffer (125 mM Tris/HCl pH 6.8, 20% Glycerol, 17 % SDS, 
0.015% Bromphenol blue, 5%β-mercaptoethanol) was added and samples were incubated at 
97°C for 5 minutes. Samples were either frozen at -20°C or directly subjected to SDS-PAGE. 
2.2.3.2. One-dimensional SDS-polyacrylamid-gelelectrophoresis (SDS-PAGE) 
To perform discontinuous gel electrophoresis, 40-100 µg proteins were applied in Laemmli 
buffer as described before (2.3.1). Proteins first passed through a stacking gel to become 
concentrated and then passed through the separating gel to be separated according to molecular 
size under denaturating conditions. The SDS polyacrylamide gel was prepared with the help of 
the mini-protean II cell system (BioRad, Munich, Germany), whose components are shown in 
table 1. SDS-PAGE was performed in SDS-PAGE running buffer (Table 1) at 100 volt at RT 
using the Mini Trans Blot system (BioRad). 
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Table 1.Different concentrations of SDS-PAGE gel compounds 
   Seperating gel Stacking gel 
Concentration 8 % 10 % 5 % 
Double distilled water 4.6 ml 4.0 ml 3.4 ml 
Rotiphorese®Gel 30 2.7 ml 3.3 ml 0.83 ml 
Buffer (1.5 M Tris-HCl, pH 8.8) 2.5 ml 2.5 ml - 
Buffer (1 M Tris-HCl, pH 6.8) - - 0.63 ml 
10 % SDS 100 µl 100 µl 40 µl 
20% ammonium persulfate (APS) 50 µl 50 µl 20 µl 
N, N, N’, N’-Tetramethylethylenediamine 
(TEMED) 
6 µl 4 µl 8 µl 
 
2.2.3.3. Western blotting and immunodetection 
Western blot analysis is an immunological method to detect specific proteins by antibodies. After 
separating the proteins by SDS-PAGE (2.2.3.2), a transfer sandwich was assembled using a 
methanol activated and transfer buffer equilibrated PVDF membrane. Proteins were electrically 
transferred in the transfer buffer (Table 2) under different conditions depending on their size 
(Table 2). 
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Table 2.Transferring conditions of proteins with different sizes 
Protein size Voltage Current Time Temperature 
15 – 30 kDa 100 V 250 mA 1 hour 4°C 
30 – 50 kDa 100 V 275 mA 1 hour 4°C 
50 – 75 kDa 100 V 300 mA 1 hour 4°C 
75 – 250 kDa 100 V 300 mA 1-1.5 hour RT 
 
After disassembling the transfer sandwich, membranes were incubated in methanol for 30 
seconds and dried for at least 30 minutes at RT. After drying, membranes were incubated in 
methanol for 30 seconds and blocked in 5% Skimmed milk or BSA in Tris-buffered saline 
supplemented with 1% Tween-20 (TBST, table 3) for 1 h at RT. Blocked membranes were 
washed 3 times in TBST and incubated with the primary antibody at 4°C over night in blocking 
buffer according to the manufacturer’s instructions. After 3 times washing with TBST, the 
membranes were incubated with a horseradish peroxidase (HRP)-coupled secondary antibody for 
1 h at RT in blocking buffer according to the manufacturer’s instructions. Finally, the 
membranes were washed 3 times in TBST and subjected to chemiluminescence based detection 
using an enhanced chemiluminescence (ECL) reagent and chemiluminescence films (Amersham 
Biosciences) which were developed in an automatic film processor (CP-100, Agfa). 
Densitometric analysis was carried out using the QuantityOne software (BioRad). The primary 
and secondary antibodies are listed in table. 
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Table 3.Buffers used for western blot 
10 x running buffer 
250 mM Tris 
2 M glycine 
35 mM SDS 
dest. H2O 
Transfer buffer 
25 mM Tris 
192 mM glycine 
20 % (v/v) methanol 
dest. H2O 
TBST 
100 mM NaCl 
10 mM Tris 
0.2 % (v/v) Tween 20 
dest. H2O 
 
Table 4.Antibodies used for western blot 
Antibodies Company Species Dilution 
anti-FABP4 (aP2) Santa Cruz, sc-18661 Goat 1:1000 
anti-C/EBP Santa Cruz, sc-61 Rabbit 1:1000 
anti-C/EBP Santa Cruz, sc-150 Rabbit 1:800 
anti- UCP1 Sigma-Aldrich, U6382  Rabbit 1:500 
anti-PGC-1α Santa Cruz, sc-5816 Mouse 1:1000 
anti-PPAR Santa Cruz, sc-7273 Mouse 1:800 
anti-Pref-1 Cell Signalig Technology, #2069 Rabbit 1:1000 
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anti-β-Tubulin Dianova, DLN-09992 Mouse 1:1000 
anti-Smad4 Santa Cruz, SC-7154 Rabbit 1:1000 
anti-RhoA Santa Cruz, sc-418 Mouse 1:1000 
anti mouse-HRP Dianova, 115-035-146  1:10000 
anti rabbit-HRP Cell Signalig Technology, 7074  1:5000 
anti goat-HRP Chemicon, AP309P  1:5000 
2.2.3.4. ELISA  
Cell culture supernatants were collected every 2 days throughout in vitro differentiation. TGF1 
ELISAs were performed according to the manufacturer’s instructions (R&D Systems). 
 
2.2.4. DNA/RNA analysis 
2.2.4.1. Isolation of ribonucleic acids (RNA) from cells and tissues and reverse 
transcription 
Total RNA from cultured cells and tissues was isolated using the TriFast® reagent (Peqlab) 
according to the manufacturer’s instructions. For real-time PCR analysis 0.5 µg RNA were 
reverse transcribed into cDNA using the Transcriptor First Strand Synthesis Kit (Roche) and 
random hexamer primers according to the manufacturer’s instructions. For cloning, RNA was 
reverse transcribed into cDNA using oligo-dT primers. 
2.2.4.2. Isolation of desoxyribonucleic acids (DNA) from tails (genotyping) and tissues 
 
Genomic DNA from mice tails or toes was quickly isolated by protease K (table) for mice 
genotyping PCR. The purified genomic DNA was isolated from tissues with Phenol/Chloroform 
extraction method according to the manufacturer’s instructions.  
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Table 5.The quick genomic DNA isolation Substances 
Substances Volume in µl 
Protease K 2 
10 x PCR buffer with MgCl2 10 
Double distilled H2O 88 
 
 
Table 6.The quick genomic DNA isolation procedure 
Incubation temperature (°C) time 
55 overnight 
97 15 min 
4 Stored 
2.2.4.3. Polymerase-Chain-Reaction (PCR) 
To perform PCR reactions, the DNA template, a forward primer, a reverse primer, a DNA Taq 
polymerase and deoxynucleotide triphosphates (dNTPs) are required. The amplification of DNA 
fragments occurs in 3 steps: denaturation at 95°C, annealing of the primers to the DNA template 
at 52 - 65°C depending on the primers and DNA extension at 72°C. The primer sequences, 
components of the reaction mixture and PCR programs are shown as following. 
Table 7.Sequence of genotyping primers  
Primer Name Primer sequence 
oIM7859 5' - GTG CTG CAA ACC AGG AAG G- 3' 
oIM7860 5' - CTG GTT GAA TCA TTG AAG ATG G- 3' 
oIM7861 5' - CGG CAA ACG ACT GTC CTG GCC G - 3' 
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Table 8.Master mixture of regular PCR 
Substances Volume in µl 
Isolated DNA 1 
Primer oIM7859 (10 pmol/µl) 1.25 
Primer oIM7860 (10 pmol/µl) 1.25 
Primer oIM7861 (10 pmol/µl) 1.25 
dNTPs (1.25 mM each) 4 
10 x PCR buffer with MgCl2 2.5 
Taq polymerase 0.25 
H2O  13.5 
 
Table 9.Procedure of regular PCR 
Step Temperature [°C] Time [seconds] Comments 
1 94 300  
2 94 30  
3 61.8 60  
4 72 60 steps 2 – 4 were repeated 10 times 
5 72 120  
6 10 - Hold 
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2.2.4.4. Agarose gel electrophoresis 
Agarose gel electrophoresis is used for separating, identifying and purifying DNA fragments. For 
gel preparation, the appropriate amount (0.7 – 2%) of agarose was added to 1x Tris-acetic acid-
EDTA (TAE) buffer (100mM Tris, 0.11% acetic acid, 1mM Na2-EDTA) and boiled in a 
microwave (Severin). 800 ng/ml ethidium bromide were added  and the solution was poured into 
casting platforms (EmbiTech), allowed to harden at RT and placed in an electrophoresis chamber 
(Peqlab) containing 1x TAE buffer. For electrophoretic separation, 6x loading buffer (18% Ficoll 
Typ 400, 0.12 mM EDTA, 0.15% Bromphenol blue, 0.15% Xylencyanol FF in 1x TAE buffer) 
was added to the DNA and samples were loaded on the agarose gel. Electrophoresis was 
performed at 80 – 120 V at RT. DNA bands were visualized using a UV light transilluminator 
(GelDoc®XR, BioRad) at 366 nm using QuantityOne® Software (BioRad). 
Extraction of DNA fragments was performed using the illustra
TM
 GFX
TM
 PCR DNA and Gel 
band purification kit according to the manufacturer’s instructions. 
2.2.4.5. Quantitative real-time (RQ) PCR 
Quantitative real-time (qRT) PCRs were performed according to the SYBR Green kit on mRNAs 
analysis or TaqMan®MicroRNA Kit (Applied Biosystem, USA) on miRNAs analysis.  
SYBR Green I is a dye which intercalates into double-stranded DNA thereby producing a 
fluorescence signal. The intensity of the signal is proportional to the amount of double-stranded 
DNA present in the reaction. Therefore, the intensity increases with each cycle of the PCR 
reaction as the amount of the product increases. SYBR Green qRT-PCRs were accomplished 
using the LightCycler® SYBR Green I Master mix (Roche) on a StepOnePlus™ Real-Time PCR 
System (Applied Biosystems; 96-well format). The primer sequences, components of the 
reaction mixture and PCR programs were run as following. 
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Table 10.Primers’ sequence of qRT-PCR 
Primer Name Primer sequence 
UCP1 forward 5' - GGT GAA CCC GAC AAC TTC CGA AGT G - 3' 
UCP1 reverse 5' - GGG TCG TCC CTT TCC AAA GTG TTG A - 3' 
PGC-1α forward 5' - GCA CAC ACC GCA  ATT CTC CCT TGT A - 3' 
PGC-1α reverse 5' - ACG CTG TCC CAT GAG GTA TTG ACC A - 3' 
Cidea forward 5' - ATT TAA GAG ACG CGG CTT TGG GAC A - 3' 
Cidea reverse 5' - TTT GGT TGC TTG CAG ACT GGG ACA T - 3' 
HPRT forward 5' - ACA TTG TGG CCC TCT GTG TGC TCA - 3' 
HPRT reverse 5' - CTG GCA ACA TCA ACA GGA CTC CTC GT - 3' 
C/EBPα forward 5' - CGA GGA GGA CGA GGC GAA GCA - 3' 
C/EBPα reverse 5' - TGC GCA GGC GGT CAT TGT CAC - 3' 
C/EBPβ forward 5' - CAC CAC GAC TTC CTC TCC GAC CTC T - 3' 
C/EBPβ reverse 5' - GTA CTC GTC GCT CAG CTT GTC CAC C - 3' 
aP2 forward 5' - TGA AAG AAG TGG GAG TGG GCT TTG C - 3' 
aP2 reverse 5' - CAC CAC CAG CTT GTC ACC ATC TCG T - 3' 
PPARγ2 forward 5' - TCC GTA GAA GCC GTG CAA GAG ATC A - 3' 
PPARγ2 reverse 5' - CAG CAG GTT GTC TTG GAT GTC CTC G - 3' 
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Table 11.Master mix of qRT-PCR 
Substance Volume in µl 
2 x SYBR Green I Master mix 4 µl 
Primer forward (5 pmol/µl) 1 µl 
Primer reverse (5 pmol/µl) 1 µl 
cDNA 5 µl 
 
Table 12.Procedure of qRT-PCR 
Step Temperature [°C] Time [seconds] Comments 
1 95 600  
2 95  10  
3 72 15 steps 2 – 5 were repeated 40 times 
4 72 90  
5 82 1 single acquisition 
6 95 1 Melting Curve begins 
7 65 15 20 acquisitions per °C 
from 65°C to 95°C 8 95  
9 4 hold  
 
Single miRNA is reverse transcribed to cDNA with specific RT-primer, and then the the cDNA 
is amplified by primer with TaqMan® probe, both primers are from TaqMan®MicroRNA Kit. 
The probe will be activated to produce fluorescence signal, when the extending step is end at per 
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cycle. The intensity frequently increases with each cycle of the PCR reaction as the amount of 
the activated probe increases.  
miRNAs’ specific RT-primers and qRT-PCR primers were purchased from Applied Biosystems 
(Table 13). ABi qRT-PCRs accomplished using the TaqMan® Universal PCR Master Mix 
(Applied Biosystems) on a StepOnePlus™ Real-Time PCR System (Applied Biosystems; 96-
well format) according to the manufacturer’s instructions (Table 14 and Table 15). 
Table 13.miRNAs’ assay kits (including RT-primers and qRT-PCR primers) ID from Applied Biosystem 
miRNAs  Assay ID (ABi) 
mmu-miR-155 002571 
mmu-miR-146a 000468 
mmu-miR-148a 000470 
mmu-miR-673 001954 
mmu-miR-615 001960 
mmu-miR-30e 002223 
mmu-miR-340 002258 
mmu-miR-223 002295 
mmu-miR-409-3p 002332 
mmu-miR-805 002045 
mmu-miR-21 000397 
mmu-miR-27b 000409 
mmu-sno-202 001232 
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Table 14.Master mix of qRT-PCR on miRNA 
Substance Volume in µl 
Product from miRNA RT 
reaction 
1.33 µl 
TaqMan® Universal PCR 
Master Mix 
10 µl 
TaqMan® Small RNA Assay 
(20x) 
1 µl 
H2O 7.67 µl 
 
Table 15.Procedure of qRT-PCR on miRNA 
Step Temperature [°C] Time [seconds] Comments 
1 95 600  
2 95  15  
3 60 60 steps 2 – 3 were repeated 40 times 
4 4 hold  
 
Relative quantification of mRNA levels was performed based on the crossing point (CP) values 
of the amplification curves using the ΔΔCT method. Hypoxanthine-guanine-
phosphoribosyltransferase (HPRT) served as an internal control to mRNA, and snoRNA202 
were set as the endogenous control to miRNA. 
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2.2.4.6. Generation of lentiviral miRNA or mRNA expression constructs 
Lentiviral expression constructs were used to stably express proteins of interest (Table 16). The 
constructs were derived from the pRRL.SIN-18 vector, containing sequences of HIV-1 and the 
transgene of interest. The pRRL.SIN-18 vector system contains no wild type copies of the HIV-
long terminal repeats (LTRs): the 5’-LTR is chimeric and contains an enhancer and promoter of 
the respiratory syncital virus (RSV) instead of the U3-region of the wild type HIV (RRL). The 
U3-region in the 3’-LTR was nearly completely deleted. Therefore, both LTRs are  
transcriptionally inactivated (self-inactivating (SIN) vector) (Dull et al., 1998). The original virus 
plasmids were provided by Inder Verma (The Salk Institute for Biological Studies, Laboratory of 
Genetics, and La Jolla, CA, USA). Preparation of the lentivirus was accomplished by the 
lentiviral vector platform of the Institute of Pharmacology and Toxicology at University of Bonn. 
miRNA precursors were amplified from genomic DNA according to normal PCR procedure. 
Fragments were ligated into two restriction enzyme sites of target vector (Table 17). Briefly 
speaking, fragments of miRNA precursors were amplified by PCR, and then brought into 
pCR®2.1-TOPO® vector (Invitrogen) using The Original TA Cloning® Kit (Invitrogen) 
according to the manufacturer’s instructions. The two designed restriction sites of the cDNA 
fragments were used to retrieve the cDNA fragment from the pCR®2.1-TOPO® vector and 
ligate it into the target vector CMVpRRL.SIN18 or PGKpRRL. SIN18 expression vectors which 
carries green fluorescent protein (GFP) as reporter.  
mRNA C/EBPβ cDNA was digested with two restricted enzymes (NEB) from pcDNA3.1-
C/EBPβ purchased from Addgene (www.addgene.org) and sub-cloned into target vector 
CMVpRRL.SIN18 or PGKpRRL without GFP. 
Anti-miR-155 construct, miR-155 Sponge, is carried 10 repetitive miR-155 binding sites to soak 
up endogenous miR-155(Table 18) (Ebert et al., 2007). The sponge construct was sub-cloned in 
to CMVpRRL.SIN18 with GFP as reporter. 
Insertions were checked by specific restrict enzymes (NEB) digestion, then the made plasmid 
vectors were sent to Eurofins MWG for sequencing confirmation. 
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Table 16.Basic information of lentiviral plasmids concerning to the study 
Vector Backbone Promoter Transgene Source 
LVcontrol pRRL.SIN18 ------------ ------------ AG Pfeifer 
LVC/EBPβ pRRL.SIN18 CMV C/EBPβ Y. Chen 
LVC/EBPβ pRRL.SIN18 PGK C/EBPβ Y. Chen 
LVmiRctrl pRRL.SIN18 CMV GFP-miR-scramble H. Lehman / Y. Chen 
LVmiR155 pRRL.SIN18 CMV GFP-miR-155 Y. Chen 
LVmiR155 pRRL.SIN18 PGK GFP-miR-155 Y. Chen 
LVmiR155 pHPWLM mu-UCP1 GFP-miR-155 M. Von Osten/ B. Haas 
LVmiR155 pHPWLM rat-UCP1 GFP-miR-155 M. Von Osten/ B. Haas 
LVmiR146a pRRL.SIN18 CMV GFP-miR-146a Y. Chen 
LVmiR223 pRRL.SIN18 CMV GFP-miR-223 H. Lehman / Y. Chen 
LVmiR143 pRRL.SIN18 CMV GFP-miR-143 F. Siegel 
LVmiR9* pRRL.SIN18 CMV GFP-miR-9* AG Pfeifer 
LVmiR195 pRRL.SIN18 CMV GFP-miR-195 AG Pfeifer 
LVmiR145 pRRL.SIN18 CMV GFP-miR-145 AG Pfeifer 
LVmiRS155 pRRL.SIN18 CMV GFP-Sponge-155 S. Kipschull / Y. Chen 
LVT/OmiR155 pLenti6.3 CMV/TO GFP-miR-155 S. Kipschull / Y. Chen 
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Table 17.Primers’ sequence for cDNA amplification of miRNA precursors 
Primer names Primer sequences 
miR-155 fwd PstI 5'- CTAC ctgcag TCAAAGCTGAAGTCTACCTTGCC -3' 
miR-155 rev EcoRv 5'- CTAC gatatc AGCAGGGTGACTCTTGGACTTG-3' 
miR-146a fwd EcoRv 5'- CTAC gatatc TGTCCCAGATCCTTATGCATCA-3' 
miR-146a rev SalI 5'- CTAC gtcgac TCAATCCAACATGACTCCCTCC-3' 
miR-223 fwd EcoRv 5'- CTAC gatatc TCTTTCCAGTTGCACATCTTCC-3' 
miR-223 rev SalI 5'- CTAC gtcgac GCATTCATATGTAGGCAGCAGG-3' 
 
Table 18.Sponge-miR-155 sequence of anti-miR-155 casstte in LV-mirS155 plasmid 
Sponge name Sponge sequence 
Sponge-miR-155 5'actagtACCCCTATCAGTCTAGCATTAAGGGTTTACCCCTATCAAT
GTAGCATTAACACAGAACCCCTATCAGAGTAGCATTAAGAGCAG
ACCCCTATCATTGTAGCATTAAGTGGAAACCCCTATCAACTTAGC
ATTAACCTTGAACCCCTATCAAGGTAGCATTAAGGACCAACCCC
TATCATACTAGCATTAACGAGATACCCCTATCATCTTAGCATTAA
CCAGGTACCCCTATCAGGATAGCATTAAGGTGCTACCCCTATCA   
GCCTAGCATTAAtctaga-3' 
 
2.2.4.7. Generation of constructs for luciferase reporter assays on mRNA 3’-UTR 
In luciferase reporter assays on miRNAs and 3’-UTR of mRNAs, constructs are used containing 
the luciferase gene as reporter of the 3’-UTR including miRNAs binding “seed” site of interest 
mRNAs. To generate a plasmid carrying the firefly luciferase with 3’-UTR of C/EBPβ, a 550bp 
fragment of the C/EBPβ 3’-UTR region was cloned into the SpeI and SacI sites of the firefly and 
Renilla luciferase Dual-expressing vector pMIR-RNL-TK (Figure 10) which contains herpes 
simplex virus thymidine kinase (TK) and SV40 promoters that promote firelyfly and Renilla 
Materials and Methods 
43 
 
genes expression, therefore firefly expression can be used as reporter and Renilla gene 
expression can be used as control.  
The 550bp fragment of the C/EBPβ 3’-UTR region was generated from genomic DNA by PCR 
using the following primers which exhibited a SpeI and SacI recognition site (Table 19). 
                
Figure 10.The plasmid vector map for pMIR-RNL-TK which was used to carry mRNA-3’UTR cassette. 
 
Table 19. Primer sequences for amplification of C/EBPβ-3’UTR and mutation of miR-155 binding sites  
Primer names Primer sequences 
C/EBPβ-UTR fwd SpeI 5' - TAT act agt GAG AAA AGA GGC GTA TGT ATA T - 3' 
C/EBPβ-UTR rev SacI 5' - ACC gag ctc CCA AAC AGG CGT GCG GTC TCC - 3' 
C/EBPβ-UTR fwd mut 5'- GAG AAC CTT TTC CGT TTC GTT GTG ACG CGT GAA GAC ATT 
TTA ATA AAC - 3' 
C/EBPβ-UTR rev mut 5'- GTT TAT TAA AAT GTC TTC ACG CGT CAC AAC GAA ACG 
GAA AAG GTT CTC - 3' 
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The resulting fragment was ligated into the pCR®2.1-TOPO® vector (Invitrogen) using The 
Original TA Cloning® Kit (Invitrogen) according to the manufacturer’s instructions.  The SpeI 
and SacI recognition sites of the DNA fragment were used to retrieve the fragment from the 
vector and ligate it into the pMIR-RNL-TK dual-luciferase vector. The “seed” mutation has been 
performed using the  Quick-Change Site Directed Mutagenesis Kit (Stratagene) with  primers 
designed according to the manufacturer’s instructions. 
Insertion was checked by EcoRV digestion. The finial plasmid DNA was sent to Eurofins MWG 
for sequencing confirmation. 
2.2.4.8. Promoter analysis and luciferase assay 
Computational analysis of the BIC/miR-155 promoter sequence for identification of putative 
transcription factor binding sites was performed using the TFSEARCH ver.1.3 database.  
For the luciferase reporter assay on promoter of miR-155, miR-155/BIC promoter construct in 
pGL3 plasmid was a kind gift from Prof. Flemington. The pGL3-miR-155/BIC construct is 
formed with miR-155 promoter and luciferase firefly gene as reporter. The pRL-TK vector 
(Promega) was co-operated to serve as an internal control expressing Renilla luciferase under 
control of the TK promoter. 
2.2.4.9. Deep sequencing 
Deep sequencing (including miRNA cloning and library sequencing) was performed by Vertis 
Biotech (Munich, Germany). 
2.2.4.10. Chromatin immunoprecipitation 
Wild type primary brown preadipocytes were transduced with LVC/EBPβ or LVcontrol. ChIP 
assay was performed following the manufacturer’s instructions (Agarose ChIP kit, Pierce). An 
anti-C/EBPβ antibody (Santa Cruz) was used to precipitate C/EBPβ-bound DNA. qRT-PCR 
analysis on recovered DNA fragments was performed using primers that span the putative 
C/EBPβ binding sites A, B/C/D, or E respectively. qRT-PCR results were normalized to input 
values. 
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Table 20. Primer sequences for C/EBP binding site ChIP assay 
Primer names Primer sequences 
ChIP C/EBPβ A fwd 5' – TGT GTG GTA GGA AGA AAA CCT TCA - 3' 
ChIP C/EBPβ A rev 5' – TGT CAG ATT CGT GGA CAC AGA AA - 3' 
ChIP C/EBPβ B/C/D fwd  5' – CCA GAT ACT ACA GGG ATC TAA AGA GGT T - 3' 
ChIP C/EBPβ B/C/D rev 5' – TCA GGC CTT CCC CTA AAA CTC - 3' 
ChIP C/EBPβ E fwd 5' – CAG AGT GAC CTG CCT TAT CTT AAA AA - 3' 
ChIP C/EBPβ E rev 5' – GAC CCT TTA ATA CAG TTC CTT CTG TTG - 3' 
 
2.2.5. Respiratory measurements in cultured adipocytes and tissue 
Analysis of mitochondrial function is central to the study of energy metabolism and thermogenic 
activity in brown fat cells. However, important properties of mitochondria differ in vivo and in 
vitro. To study mitochondrial function in BAT and in cultured brown adipocytes, a protocol for 
the in situ analysis of functional mitochondria in selectively permeabilized cells using digitonin, 
without the isolation of organelles, was applied (Kuznetsov et al., 2008). 
Adipose tissue (about 3-6 mg BAT or 30-50 mg inguinal WAT) from 12-16 week old, cold-
exposed (4 h, 4°C) wt, miR-155
+/-
, or miR-155
-/-
 mice was isolated immediately before 
oxygraphic measurements (Oxygraph 2K, Oroboros Instruments). Tissue was dissected into 
small pieces and transferred to the oxygraph chamber containing 2ml incubation medium 
(0.5mM EGTA, 3mM MgCl2.H2O, 60mM K-lactobionate, 20mM Taurine, 10mM KH2PO4, 
20mM HEPES, 110mM Sucrose, 1g/l BSA, and pH7.1) with 25μg/ml digitonin. Ex vivo 
respiration levels of the adipose tissues were recorded when reaching a steady state. Respiration 
rates were normalized to total protein content. 
Additionally, the maximal mitochondrial oxygen consumption in permeabilized cells and tissue 
under maximal substrate availability conditions as well as the UCP-1-dependent fraction were 
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determined. Therefore, a substrate/inhibitor titration protocol was applied. The following 
substances were added to the chamber using Hamilton syringes to the indicated final 
concentrations in the stated order. After adding a substance, it was waited until the respiration 
rate reached a steady state, then the next substance was added. 
Table 21.Substances used in respiratory measurements 
Substance Final concentration Function 
Digitonin 25 µg/ml Permeabilization 
Glutamate/Malate 10 mM each Substrate 
Succinate 10 mM Substrate 
ADP 2 mM Substrate 
Oligomycin 10 µg/ml Inhibitor 
 
To measure cold-induced thermogenesis in differentiated brown adipocytes in vitro, the cells 
were pretreated with 1 mM 8-Br-cAMP for 24 h prior to the respiratory measurements to mimic 
cold exposure.  
The obtained respiration rates were normalized to the protein content of determined by the 
Bradford method from reference wells. 
2.2.6. Statistics 
Values are presented as means ± standard error of means (SEM). Statistical differences between 
two means were determined using Student’s t-test (unpaired, two-tailed), one-way ANOVA was 
used to compare differences among multiple groups. GraphPad Prism 5 or Excel software was 
used to calculate P-values (*P < 0.05; **P < 0.01; ***P < 0.001). 
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3. Results 
3.1. Identification of miRNAs with a function in brown adipogenesis 
3.1.1. Genome-wide profiling of miRNAs in brown fat  
Mature brown adipocytes are derived from BAT-MSCs. To identify miRNAs that play a role 
during brown adipogenesis, we compared miRNA expression profiles of preadipocytes isolated 
from the SVF of BAT (Haas et al., 2009) with in vitro differentiated mature brown adipocytes by 
a global deep sequencing analysis. 288 miRNAs could be detected in this screen: 16 miRNAs 
were >2fold higher expressed in mature adipocytes compared to preadipocytes, whereas 12 
miRNAs were >2fold down-regulated during differentiation (Figure 11). 
        
Figure 11. Genome-wide deep sequencing screen to identify differentially regulated miRNAs in brown 
adipocytes. Shown are the 16 up-regulated and 12 down-regulated miRNAs with fold changes > 2. 
 
3.1.2. Validation of miRNA candidates 
In order to confirm the most differentially regulated miRNA candidates, we selected 12 miRNAs 
according to relevance of their putative target genes (www.targetscan.org), as well as by 
literature search on known function of the identified miRNA candidates 
(www.ncbi.nlm.nih.gov/pubmed). The expression of these selected miRNAs was validated by 
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quantitative Real-time PCR (qRT-PCR) in preadipocytes and in vitro differentiated brown fat 
cells (Figure 12). 
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Figure 12. qRT-PCR analysis of miRNA expression in preadipocytes (stromal vascular fraction) isolated 
from brown fat tissue (BAT-SVF) versus in vitro differentiated mature adipocytes. Data are normalized to 
sno202RNA expression and are represented as means ± SEM. (*p<0.05, ***p<0.001, n=6).  
 
Three miRNA candidates from the deep sequencing screen could be validated by qRT-PCR: 
miR-146a (about 3.57 fold increased in mature brown adipocytes , p<0.05), miR-155 (about 4.12 
fold decreased, p<0.001), and miR-223 (about 4.6 fold increased, p<0.05).  
 
3.1.3. Lentiviral expression vectors for efficient miRNA expression 
To analyze these miRNAs in more detail lentiviral expression vectors carrying optimized 
miRNA precursor expression cassettes for efficient miRNA expression under control of the 
constitutively active CMV promoter were generated. The miRNA precursor sequences were 
cloned into the 3´UTR of the GFP reporter gene open reading frame (ORF). A non-matching 
scrambled sequence was used as control (miRctrl) (Figure 13). 
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Figure 13. Lentiviral expression vectors; LVmiRs express miRNA precursors (yellow) coupled to GFP 
mRNA as reporter (green), LVmiRctrl contains a scrambled, non-targeting sequence. LTR, long terminal 
repeat; cPPT, central polypurine tract; CMV, cytomegalovirus promoter; GFP, green fluorescent protein; 
pre-miR-155, precursor miR-155; WPRE, woodchuck hepatitis responsive element; triangle, self-
inactivating mutation.  
 
The miRNA-carrying lentiviruses effectively infected the cultured BAT preadipocytes (BATi 
cells). At 48 h post transduction, GFP reporter expression was observed under the florescence 
microscope to evaluate transduction efficiency (Figure 14) 
 
                                    
Figure 14. Lentiviral transduction efficiency in preadipocytes (BATi). LVmiR155 transduced cells were 
observed under the microscope to evaluate the percentage of GFP positive cells. Un-transduced 
preadipocytes served as controls (representative images are shown). 
Bright field Fluorescence 
 
untransduced 
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Transduction of preadipocytes with GFP/ miRNA carrying lentiviruses showed high efficiencies. 
Between 99.2% and 99.9 % cells were detected as GFP positive by using flow cytometry (FACS) 
analysis. 
  
3.1.4. Role of identified miRNA candidates in brown adipogenesis 
To investigate miRNA function in  brown fat differentiation, preadipocytes (BATi) were infected 
with the miRNA-expressing viruses (day -4) and fully differentiated until day 8 in vitro using the 
standard brown fat differentiation protocol (see 2.2.2.5.).  
To measure fat differentiation in vitro, lipid droplets of mature differentiated brown fat cells 
were stained with Oil Red O substrate. 
As shown in Figure 15, miR-146a slightly reduced lipid accumulation, whereas miR-155 
strongly reduced the number of lipid droplets. In contrast, overexpression of miR-223 had a 
slightly increased amount of lipid droplets. 
These findings suggest that miRNAs can both activate and inhibit the accumulation of lipid 
droplets of brown fat cells in vitro. 
                
    
Figure 15. Oil Red O staining shows the effects of miRNA overexpression on brown fat lipid 
accumulation, and differentiation in vitro 
 
3.2. Role of miR-155 in brown adipocytes 
3.2.1. Regulation of miR-155 in brown adipogenic differentiation 
Since miR-155 has such a strong effect on lipid accumulation, we selected it for further studies 
during brown adipocyte differentiation. miR-155 was shown to play a role in the context of 
hematopoiesis, immune response, and tumor formation (Eis et al., 2005). In contrast the 
knowledge of miR-155 function in adipose tissue is very limited. 
miR-ctrl miR-146a miR-223 miR-155 
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First, I studied ex vivo expression of miR-155 in brown fat cell types, total RNA was isolated 
either from the stromal vascular fraction or the mature fat fraction of BAT. I found that miR-155 
expression is remarkably lower in the mature fat fraction than in the SVF of BAT (Figure 16A).  
To further elucidate the role of miR-155 in adipogenesis, SVF-derived preadipocytes were 
purified by FACS sorting. Purified BAT progenitors positive for the preadipocyte/stem cell 
marker Sca1 and negative for the hematopoietic markers CD45 and Mac1 (Schulz et al., 2010) 
were then cultured on cell culture dish for 48 h in vitro. Comparative qRT-PCRs were performed 
in unsorted vs. FACS-sorted BAT-SVF cells. Data showed that there was no significant 
difference of miR-155 expression between the sorted and unsorted BAT-SVF cells (Figure 16B). 
Finally, total RNA was isolated from unsorted preadipocytes, and from in vitro differentiated 
BAT cells at day 7/8. The results indicated miR-155 expression is strongly reduced in 
differentiated brown fat cells (Figure 16C). These experimental data demonstrated that miR-155 
is downregulated during brown fat differentiation in vivo (Figure 16A), as well as in vitro (Figure 
16C). 
 
Figure 16. miR-155 regulates brown fat differentiation ex vivo and also in vitro. qRT-PCR analysis of 
miR-155 expression (A) in BAT tissue samples, the SVF or the mature adipocyte fraction of new-born 
mice were used. SVF value was set as one; data are represented as means ± SEM (***P<0.001; n=3); (B) 
in BAT cells from the SVF, or Sca-1
+
, CD-45
-
 and Mac-1
-
 FACS-sorted BAT preadipocytes; (C) in 
preadipocytes and in vitro differentiated mature fat cells. The preadipocyte group was set as one data are 
represented as means ± SEM (n.s., not significant; ***P<0.001; n=3). (All data are normalized to 
snoRNA202 expression.) 
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3.2.2. miR-155 inhibits brown adipocyte differentiation in vitro 
Overexpression of miR-155 has been shown to reduce lipid accumulation in vitro, and its 
expression was down-regulated significantly in mature brown fat in vivo as well as in vitro 
(Figure 16A, C). To further investigate the effects of miR-155 in brown adipocytes 
differentiation in vitro, the experiments with lentiviral vectors were performed. Apart from 
overexpression of miR-155 (LVmiR155), we investigated the effects of a knock-down of 
endogenous miR-155 by a lentiviral vector carrying a miR-155-specifc octameric decoy target 
(LVmiRS155) – a so called `sponge´ (Ebert et al., 2007) – that competitively inhibits miR-155. 
A vector carrying a scrambled miRNA sequence was used as control (LVmiRctrl) (Figure 17A).  
To measure miR-155 expression levels in the lentiviral transduced cells, total RNA was isolated 
48 h post infection. qRT-PCR data showed, that miR-155 expression was increased 20-fold in 
LVmiR155 transduced cells. In contrast, transduction with the “sponge” construct (LVmiRS155) 
resulted in a 70% reduction of miR-155 levels (Figure 17B). 
                                   
 
                 
Figure 17. (A) Lentiviral expression vectors; LVmiR155 expresses miR-155 precursors (yellow) coupled 
to GFP mRNA as reporter (green), LVmiRctrl contains a scrambled, non-targeting sequence (yellow), 
and LVmiRS155 contains ten repeats of a miR-155 complementary binding site (blue). LTR, long 
terminal repeat; cPPT, central polypurine tract; CMV, cytomegalovirus promoter; GFP, green fluorescent 
protein; pre-miR-ctrl, scrambled miRNA sequence; pre-miR-155, precursor miR-155; blue boxes, decoy 
targets; WPRE, woodchuck hepatitis responsive element; triangle, self-inactivating mutation. (B) qRT-
PCR analysis of miR-155 expression levels in LVmiR155 and LVmiRS155 transduced preadipocytes 
(normalized to snoRNA202). Untreated cells (mock) were set as one; data are presented as mean±SEM 
(***P<0.001; **P<0.01; n=3). 
 
miR-155 overexpressing cells revealed a strong inhibition of lipid accumulation. These results 
were reflected in decreased tri-glycerol content of differentiated LVmiR155 transduced cells 
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(Figure 8). In contrast, LVmiRS155 transduced cells displayed a significant increase in lipid 
droplet number and size as well as in tri-glycerol (TG) content (Figure 18A, B). 
                     
Figure 18. (A) Oil Red O staining of BATi cells overexpressing miR-155 (LVmiR155) or an anti-miR-
155 sponge (LVmiRS155) as compared to cells carrying a control scrambled miRNA (LVmiRctrl); mock, 
uninfected cells. (B) TG content of differentiated BAT cells transduced with LVmiRctrl, LVmiR155, and 
LVmiRS155; mock, uninfected control. TG content was normalized to total protein concentration. 
Untreated cells were set as one. Data are represented as means ± SEM. (*P<0.05; n=4). 
 
The effect of miR-155 in brown adipocytes differentiation is also validated by data from 
expression analysis of adipogenic marker genes. Western blotting experiments revealed that 
overexpression of miR-155 significantly reduced abundance of the adipogenic markers C/EBP, 
PPAR, and aP2, whereas expression of the miR-155 sponge effectively increased abundance of 
these markers as compared to wt cells or LVmiRctrl transduced cells (Figure 19).  
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Figure 19. (A) Representative Western blot of fat cell markers C/EBP, PPARγ, and aP2 in 
differentiated brown adipocytes transduced with lentiviral vectors LVmiRctrl, LVmiR155, and 
LVmiRS155, respectively; mock, uninfected control. Tubulin served as loading control. (B) 
Quantification of Western blot analysis of fat cell markers. Uninfected controls (mock) were set as one. 
Expression data were normalized to Tubulin and are represented as means ± SEM. (*P<0.05; **P<0.01; 
***P<0.001; n=4). 
 
Furthermore, three thermogenic markers of brown adipocytes: UCP1, PGC-1α and Cidea, were 
shown to be reduced in miR-155 overexpressing cells. Interestingly, the opposite effects were 
observed in the miR-155 knock-down group (LVmiRS155) (Figure 20).  
These qRT-PCR data indicated that not only regular fat cell differentiation, but also the brown 
fat-specific thermogenic program were inhibited by miR-155.    
                                                   
Figure 20. qRT-PCR analysis of the brown thermogenic markers PGC-1α, UCP1, and Cidea in 
differentiated brown adipocytes transduced with the indicated lentiviral vectors. Untreated cells (mock) 
were set as one. Data were normalized to HPRT, a reference gene, expression and are represented as 
means ± SEM. (*P<0.05; **P<0.01; n=4). 
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Taken together, these data revealed that during brown adipocytes differentiation, miR-155 
overexpression showed a strong effect: LVmiR155 transduced cells exhibited a strong reduction 
of both thermogenic and adipogenic gene expression, less fat droplets, and less TG content. Thus, 
these data indicate that miR-155 inhibited brown adipocyte differentiation in vitro. 
 
3.3 C/EBPβ is the major target of miR-155 in brown adipocyte differentiation 
It has been shown that miRNAs can target multiple-mRNAs via binding to partial 
complementary binding sites. Thereby, one miRNA might be able to influence the translation of 
many target genes in one certain cell type or tissue. In addition, miRNA abundance and 
relevance of a given miRNA-target interaction is cell type specific.  
To understand the inhibitory role of miR-155 in brown fat differentiation, identification of the 
major target of miR-155 in brown fat cells is crucial.  
3.3.1 miR-155 targets C/EBPβ in brown adipocytes 
Databases are currently annotating more than 250 predicted conserved miR-155 target genes in 
mouse and human UTR (www.targetscan.org). A plethora of validated targets of miR-155 have 
been reported for hematopoietic and immune cells (O'Connell et al., 2008). Interestingly, 
C/EBP has been identified as a primary target of miR-155 in lymphocytes, myeloid cells and 
macrophages (Costinean et al., 2009; He et al., 2009; O'Connell et al., 2009; Worm et al., 2009), 
as well as in vitro models of white adipogenesis (Liu et al., 2011). C/EBP has a conserved 
8-mer binding site for miR-155 in its 3´UTR (Figure 21).  
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Figure 21. Schematic representation of C/EBPβ mRNA including the 3´UTR containing the predicted 
miR-155 target region (top). Sequence alignment of the highly conserved miR-155 3´UTR binding site in 
mice (Mmu), rat (Rno), and human (Hsa) with the seed region of the mature 22nt miR-155 
(www.targetscan.org) (bottom). 
 
The transcription factor C/EBPβ is one of the essential regulators of the early phase of adipocyte 
differentiation. Moreover, recent studies showed that C/EBPβ is not only important in 
adipogenesis, but is also a crucial factor in the thermogenic program in brown fat (Kajimura et 
al., 2009). For C/EBPβ, three different polypeptides are generated: two activating forms termed 
LAP and LAP* (liver-enriched transcriptional activator protein, 35kDa and 38kDa) and one 
inhibitory form named LIP (liver-enriched transcriptional inhibitory protein, 20kDa) (Nerlov, 
2007). All three isoforms arise from one single mRNA transcript by alternative, in-frame 
translation initiation sites (Calkhoven et al., 2000) and all isoforms are expressed in 
differentiated brown adipocytes. In our brown fat in vitro differentiation procedure, all three 
C/EBPβ isoforms were strongly induced by induction medium (IM). Especially, LAP was highly 
abundant after stimulation by IM (Figure 22A). We found that miR-155 down-regulates all three 
isoforms simultaneously in in vitro differentiated brown adipocytes (Figure 22B).  This can be 
explained by the fact that the three C/EBPβ isoforms share the same 3´UTR containing the 
miR-155 recognition site. 
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Figure 22. Western blot analysis of C/EBPβ isoform (LAP*/ p38, LAP/ p35, and LIP/ p20) expression 
(A) in BAT cells with or without induction, overexpression of C/EBPβ with lenti-viral transduction 
(LVC/EBPβ) was set as positive control group; (B) in untransduced (mock), LVmiRctrl or LVmiR155 
transduced brown mature adipocytes (day 8). 
 
In our next analysis, we were focusing on the LAP isoform, because this is the predominant one 
in brown adipocytes and has been shown to bind to PRDM16 (Kajimura et al., 2009). Given the 
importance of C/EBP for brown adipogenesis and the inhibitory function of miR-155 on 
C/EBPβ protein levels in LVmiR155 transduced adipocytes, we further investigated the 
interaction of miR-155 and C/EBPβ in brown fat differentiation (Figure 23A). 
To test direct interaction of miR-155 with C/EBP, we generated a luciferase construct carrying 
the C/EBP 3´UTR sequence (Figure 23A top). For these reporter assays we used the the murine 
HIB-1B brown preadipocyte cell line. HIB-1B cells transduced with LVmiR155 showed a 
reduced luciferase expression compared to wt or LVmiRctrl transduced cells. Mutagenesis of the 
miR-155 binding site in the C/EBP 3´UTR clearly abolished the miR-155 mediated suppression 
of luciferase activity (Figure 23B bottom). 
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Figure 23. (A) Western Blot analysis (top) of C/EBPβ expression in cells transduced with LVmiRctrl or 
LVmiR155; mock, uninfected cells. Quantification of Western blot analysis (bottom), tubulin served as 
loading control. Untreated cells (mock) were set as one. Data are represented as means ± SEM. 
(**p<0.005; n=3). (B) Luciferase assay to examine interaction between miR-155 and its predicted target 
site in the C/EBPβ 3´UTR. Reporter plasmids carrying the wt or mutated C/EBPβ 3´UTR (top) were 
transfected into HIB-1B cells transduced with LVmiRctrl or LVmiR155. Data are represented as means ± 
SEM. (*p <0.05; *** p <0.001; n.s., not significant, n=3). 
 
In contrast, miR-155 knock-down with the sponge construct resulted in increased C/EBPβ 
protein levels and significantly increased luciferase reporter expression (Figure 24A, B) 
                                                                 
Figure 24. (A) Western blot analysis of C/EBPβ protein levels in LVmiRctrl or LVmiRS155 transduced 
preadipocytes. Tubulin served as loading control. (B) Luciferase assay to analyze miR-155 interaction 
with the C/EBPβ 3´UTR. Reporter plasmids containing the C/EBPβ 3´UTR were transfected into 
LVmiRctrl or LVmiRS155 transduced HIB-1B cells. LVmiRctrl transduced controls were set as one. 
Data are presented as means ± SEM. (* p <0.05; n=3). 
 
These data clearly suggested that miR-155 is able to directly target C/EBPβ in brown fat 
differentiation via interaction with its 3´UTR. Next, I addressed the question whether C/EBPβ is 
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the major target of miR-155, which subsequently inhibits brown adipocyte differentiation. To 
address this question, rescue experiments were performed: Restoration of C/EBP expression 
levels were supposed to ameliorate the inhibitory effect of miR-155 in brown fat differentiation.   
 
3.3.2 C/EBPβ is able to rescue the inhibitory effect of miR-155 in brown adipocytes 
To test the hypothesis of C/EBPβ as the major miR-155 target in brown adipogenesis, miR-155 
overexpressing preadipocytes were co-transduced with a lentiviral vector carrying a C/EBP 
cDNA that does not contain the miR-155 3´UTR target sequence (LVC/EBP). To achieve 
physiologically relevant levels of C/EBP, three different concentrations of LVC/EBP were 
tested (Figure 25A). Western blot analysis revealed, that infection with 1.0 ng LVC/EBP 
resulted in “ectopic” restoration of C/EBPβ levels in LVmiR155 co-transduced cells as 
compared to the respective controls (Figure 25A) Restoration of C/EBP expression levels by 
LVC/EBPβ rescued the inhibitory effect of miR-155 on lipid accumulation as assessed by Oil 
Red O staining and measuring cellular TG content (Figure 25B, C).   
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Figure 25. (A) Western blot analysis of C/EBPβ expression in LVmiR155 cells transduced with 
increasing amounts of LVC/EBPβ to rescue the effect or miR-155 (viral titer was determined using an RT 
ELISA). Tubulin served as loading control. (B) Oil Red O staining of in vitro differentiated brown 
adipocytes infected with different combinations of lentiviral vectors expressing miR-155 (LVmiR155) 
and/or C/EBPβ (LVC/EBPβ 1 ng RTase); mock, uninfected cells; LVmiRctrl, cells transduced with a 
control scrambled miRNA lentivirus; LVcontrol, empty vector. (C) Triglyceride (TG) content of in vitro 
differentiated brown adipocytes transduced with combinations of lentiviral vectors expressing miR-155 
(LVmiR155) and/or C/EBPβ (LVC/EBPβ 1 ng RTase); mock, uninfected cells; LVmiRctrl, cells 
transduced with a lentivirus carrying a scrambled miRNA; LVcontrol, empty vector; TG content was 
normalized to total protein concentration. Untreated control was set as one. Data are represented as means 
± SEM. (*p<0.05; ***p<0.001; n=3). 
 
In addition, restoration of C/EBP protein levels reconstituted expression of the adipogenic 
markers C/EBPα, PPARγ, and aP2 in miR-155 overexpressing adipocytes to levels comparable 
to uninfected controls, as assessed by protein as well as by protein expression analysis (Figure 
26A, B). The same is true for brown fat specific, thermogenic genes: PGC-1α and UCP1 levels 
were both rescued by restoration of C/EBP in miR-155 overexpressing BAT cells (Figure 26B).  
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Figure 26. (A) Western Blot analysis of fat cell markers C/EBP, PPAR and aP2 of in vitro 
differentiated brown adipocytes transduced with combinations of lentiviral vectors expressing miR-155 
(LVmiR155) and/or C/EBPβ (LVC/EBPβ 1 ng RTase); mock, uninfected cells; LVmiRctrl, cells 
transduced with a control scrambled miRNA lentivirus; LVcontrol, empty vector. Tubulin served as 
loading control (representative blot out of n=3 is shown). (B) Abundance of adipogenic markers aP2, 
PPAR as well as of thermogenic genes UCP1 and PGC-1α as measured by qRT-PCR. Untreated cells 
(mock) were set as one; data are presented as means ± SEM. (* p <0.05; n=3).  
 
Taken together, these data show that C/EBPβ is able to rescue the miR-155 mediated inhibitory 
effect on brown adipocyte differentiation. Thus, these data indicate that C/EBPβ is the major 
target of miR-155 in brown adipocyte, and miR-155 regulates brown adipocyte differentiation 
via directly targeting C/EBPβ. 
 
 
 
 
 
 
 
 
A B 
Results 
62 
 
3.4 miR-155 is induced by the TGFβ-signaling pathway in brown preadipocytes 
To identify the physiological regulators of miR-155 in brown fat differentiation, the detailed time 
course of miR-155 expression during BAT differentiation was investigated by performing 
qRT-PCR with RNA samples isolated at day -2, day -1, day 0, day 1, day 2, day 4, and day 7/8 
of in vitro differentiation. The data revealed that miR-155 expression peaks when cells reach 
confluency at day -1 or day 0 of the differentiation protocol and decreases continuously after 
induction of adipogenesis (Figure 27) 
                          
Figure 27. qRT-PCR analysis of miR-155 expression levels in brown fat cells during in vitro 
differentiation procedure (normalized to snoRNA202). Undifferentiated cells (day -2) were set as one. 
Data are represented as means ± SEM (*p < 0.05; **p < 0.005; n=5) 
 
Transforming growth factor β 1 (TGFβ1) is known to positively regulate miR-155 via the 
TGFβ1/Smad pathway in epithelial cells (Kong et al., 2008). Furthermore, TGFβ1 has been 
shown to potently inhibit adipogenesis in 3T3-L1 cells (Ignotz and Massague, 1985). Therefore, 
we addressed the question wether TGFβ1/Smad signaling regulates miR-155 expression in BAT 
cells.  
Treatment of preadipocytes with 5ng/ml recombinant TGFβ1 significantly increased miR-155 
levels within 24h (Figure 28A), whereas inhibition of TGFβ1/Smad signaling with a 
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siRNA-Smad4 (Deckers et al., 2006) blocked TGFβ1-mediated miR-155 induction 
(Figure 28B, C).  
      
Figure 28. (A) Effect of TGFβ1 (5 ng/ml, 24 h) on miR-155 expression in brown fat cells as measured by 
qRT-PCR (normalized to snoRNA202 expression). Untreated cells were set as one. Data are represented 
as means ± SEM. (***p < 0.001; n=3).  (B) Western blot analysis of Smad4 protein levels in 
untransduced (mock), control siRNA (RVsictrl) and Smad4 siRNA (RVsiSmad4) transduced 
preadipocytes. (C) qRT-PCR analysis of miR-155 expression in RVsictrl or RVsiSmad4 transduced 
preadipocytes with or without TGFβ1 treatment (5 ng/ml; 24 h). Untreated, RVsictrl transduced cells 
served as control. Data are presented as means ± SEM. (*p <0.05; n.s., not significant; n=3).  
 
To investigate TGFβ1 expression during brown fat differentiation, cell culture supernatant was 
collected once every 2 days. ELISA was performed to measure TGFβ1 concentrations in the 
medium. Interestingly, we found that TGFβ1 was indeed expressed by brown preadipocytes and 
is regulated in a differentiation-dependent manner similar to miR-155 at the early stage of 
differentiation in vitro (Figure 29). Strongest induction of TGFβ1 in the medium was measured 
in the confluent/postconfluent phase of brown adipogenesis at day -2 to day 0, around the time-
point of maximal miR-155 expression, followed by a significant decline after cells have entered 
differentiation phase (day 0 to day 4) (Figure 29).  
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Figure 29. TGFβ1 relative protein concentrations in the cell culture supernatant and intracellular miR-
155 expression were measured by ELISA and qRT-PCR during the time course of in vitro brown fat cell 
differentiation. Both values at day-2 were set as one, data are represented as means ± SEM; (*p < 0.05; 
n=3 in TGFβ1assay; d #p< 0.05; n=5 in miR-155 assay).  
 
These findings were supported by additional analysis with the TGFβ type 1 receptor inhibitor 
SB-431542 (Inman et al., 2002). 10μM SB-431542 were used for treatment of  preadipocytes at 
the proliferation stage (day -2 to day 0), followed by the regular differentiation procedure. 
miR-155 expression was measured by qRT-PCR. The data indicated that inhibition of TGFβ1 
signaling clearly reduced miR-155 levels and abrogated its induction in proliferating brown 
preadipocytes (Figure 30).  
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Figure 30. qRT-PCR analysis of miR-155 expression in untreated (black line) or SB-431542 (TGFβ1 
receptor inhibitor; 10 μM, 48 h, gray line) treated brown fat cells during in vitro differentiation 
(normalized to snoRNA202 expression). Undifferentiated cells of the respective group at day-2 were set 
as one. Data are represented as means ± SEM. (*p < 0.05; **p < 0.005; n.s., not significant; n=5).  
 
Moreover, SB-431542 treatment not only reduced miR-155 levels (Figure 31A), but also resulted 
in enhanced in vitro adipogenesis and lipid accumulation (Figure 31B). These pro-adipogenic 
effects of inhibition of TGFβ-signaling were clearly abolished in LVmiR155-expressing cells 
indicating that miR-155 is a crucial downstream-effector of TGFβ signaling in brown 
adipogenesis (Figure 31C).  
As previously shown, TGFβ1 shows a similar expression pattern during differentiation as miR-
155, with highest expression levels at proliferation stage (Figure 30). Therefore, I aimed to prove 
that miR-155 is significantly regulated by the TGFβ1 signaling pathway at the proliferative stage 
to excert its negative effect on brown fat differentiation. Inhibition of the TGFβ1 pathway by 
SB-431542 was performed at different stages of brown fat differentiation as indicated in Figure 
31D.  
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Figure 31. (A) Effect of the TGFβ1 receptor inhibitor SB-431542 (10 μM, 24 h) on miR-155 expression 
as measured by qRT-PCR (normalized to snoRNA202). Data are represented as means ± SEM (*p < 0.05 
as compared to untreated controls; n=3). (B) Oil Red O staining of in vitro differentiated brown 
adipocytes treated with SB-431542 (10μM, day -2 to day 0); mock, untreated cells. (C) Oil Red O 
staining of fully differentiated brown adipocytes infected with LVmiRctrl or LVmiR155 and treated with 
vehicle or SB-431542 (10 μM, day -2 to day 0); mock, uninfected cells; vehicle, distilled water. (D) Oil 
Red O staining (day 8) of brown fat cells treated with 10 µM SB-431542 at indicated time points during 
in vitro differentiation. 
 
Fully differentiated BAT cells were stained with Oil Red O. The staining shows that the most 
prominent effects of SB-431542 on differentiation were observed with treatment between day -4 
to day 0, as well as between day -2 to day 0. However, stimulation with SB-431542 at day 0, 
when BAT cells were already post-confluent and entering differentiation phase had no obvious 
effect.  This result correlates with the time-point of TGFβ1-mediated induction of miR-155 
(from day -2 to day 0). 
Thus, this study indicates that the TGFβ1 signaling pathway is a major driver of miR-155 
expression in brown preadipocytes. 
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3.5 miR-155 and C/EBPβ constitute a bistable loop that regulates brown adipocyte 
differentiation 
3.5.1 C/EBPβ regulates the miR-155 promoter in brown adipocytes 
To identify mechanisms that -apart from TGFβ1- might be involved in miR-155 transcriptional 
regulation in brown fat cells, we examined the miR-155 promoter sequence for transcription 
factor binding sites. miR-155 is processed from a primary mRNA-coding transcript, the B-cell 
integration cluster (BIC)
 
(Eis et al., 2005; Yin et al., 2008). Computational analysis of the 
BIC/miR-155 promoter sequence revealed few putative C/EBP binding motifs (Figure 32) 
indicating that miR-155 might be regulated by C/EBPs or even by its own target: C/EBPβ 
through a feedback mechanism.  
 
                                  
Figure 32. Scheme of the 2 kb murine BIC/miR-155 promoter with the putative C/EBP binding sites 
(siteA, siteB/C/D, and siteE) (purple) 
 
In order to address this hypothesis, the expression of both C/EBPβ and miR-155 was “traced” 
through the whole in vitro differentiation procedure. The protein level of C/EBPβ was almost 
undetectable in preadipocytes. However, C/EBPβ was strongly induced by the adipogenic 
cocktail (IM) applied at day 0, which corresponds to the time point when miR-155 expression is 
beginning to decrease (Figure 33). In accordance with the shift of the cells from proliferation to 
differentiation state, the expression of C/EBPβ was induced while miR-155 was gradually 
reduced. 
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Figure 33. C/EBPβ protein and miR-155 expression were measured by Western-blot and qRT-PCR 
throughout the brown fat cell differentiation process. Both values at day -2 were set as one; data are 
represented as means ± SEM. 
 
To further elucidate the role of C/EBPβ in miR-155 expression, gain-of-function experiments 
were performed: Overexpression of C/EBPβ in brown preadipocytes caused a dramatic 
downregulation of miR-155 levels as compared to controls (Figure 34A). Next, we used 
BIC/miR-155 promoter luciferase reporter constructs, to analyze transcriptional regulation of 
miR-155 by C/EBPs in more detail. Lipofectamine transfection of 2 μg C/EBPs (C/EBPα, 
C/EBPβ, or C/EBPδ) for 48 h led to a strong inhibition of BIC/miR-155 promoter activity in 
HIB-1B cells. Among the C/EBPs, C/EBPβ had the most pronounced effect on the promoter 
activity (Figure 34B). The same is true, when using 200 ng RTase Lentivirus of the C/EBPβ 
construct (LVC/EBPβ) to transduce HIB-1B cells (generating a stable C/EBPβ-expressing cell 
line):  BIC/miR-155 promoter activity was significantly reduced (Figure 34C).  In contrast, 
siRNA-mediated knock-down of C/EBPβ (siC/EBPβ) (Birsoy et al., 2008) caused a significant 
increase in miR-155 expression in BAT-cells (Figure 34D, E). These data indicated that C/EBPβ 
transcriptionally inhibits miR-155 expression. 
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Figure 34. (A) qRT-PCR analysis of miR-155 expression (normalized to sno202) in cells transduced with 
LVC/EBPβ or control virus (LVcontrol). Untreated controls (mock) were set as one; data are represented 
as means ± SEM. (***p <0.001; n=3). (B) Luciferase assay to analyze regulation of the BIC/miR-155 
promoter by C/EBPs. HIB-1B cells were co-transfected with C/EBPα, C/EBPβ, or C/EBPδ expression 
vectors and the BIC/miR-155 promoter luciferase construct. Untransfected cells were set as one; data are 
represented as means ± SEM. (*p <0.05; n=3) (C) Luciferase assay to analyze regulation of the 
BIC/miR-155 promoter by C/EBPβ. Cells were infected with LVcontrol or LVC/EBPβ 48 h prior to the 
BIC/miR-155 promoter luciferase construct transfection. Uninfected controls (mock), transfected with the 
same reporter construct were set as one; data are represented as means ± SEM. (*p <0.05; n=4). (D) 
Western blot analysis of C/EBPβ expression in preadipocytes 48 h post transduction with sicontrol 
(control-siRNA) or siC/EBPβ (C/EBPβ-siRNA). (E) qRT-PCR analysis of miR-155 levels in 
preadipocytes 48 h after transduction with sicontrol or siC/EBPβ. miR-155 levels were normalized to 
snoRNA202; untransduced cells were set as one. Data are presented as means ± SEM (***p < 0.001; 
n=3). 
 
To further characterize the transcriptional regulation of miR-155 by C/EBPβ, Chromatin 
Immunoprecipitation (ChIP) assays were performed. Five putative C/EBP binding sites (siteA, 
siteB, siteC, siteD, and siteE) were identified in the BIC/miR-155 promoter sequence by using 
computational prediction software (http://www.cbrc.jp/research/db/TFSEARCH.html) (Figure 35 
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top). To identify which binding motif is the major binding site for C/EBPβ in BAT cells, brown 
preadipocytes were transduced with LVcontrol or LVC/EBPβ for 48 h, followed by chromatin 
immunoprecipitation assays with C/EBPβ-specific antibodies (ChIP-assay). The ChIP assay 
revealed a significant enrichment of the siteE containing promoter fragment in C/EBPβ-antibody 
pull-downs and thus identified the distal siteE in the BIC/miR-155 promoter as the critical 
binding site for C/EBPβ (Figure 35 bottom). 
                                 
Figure 35. Chromatin immunoprecipitation assay (ChIP) in brown preadipocytes transduced with 
LVcontrol or LVC/EBPβ 48 h prior the assay. Precipitation was performed with an anti-C/EBPβ antibody 
or IgG and PolII control antibodies. C/EBPβ bound BIC/miR-155 promoter fragments were amplified 
using qRT-PCR primers that span putative binding sites A, B/C/D, or E respectively. Results are 
normalized to input values. Relative values are represented as means ± SEM. (*p <0.05; n.s., not 
significant; n=3). 
 
Taken all together, these data indicate that miR-155 in brown adipocytes is regulated by its own 
major target: C/EBPβ. C/EBPβ interaction with the BIC/miR-155 promoter resulted in 
transcriptional repression of miR-155 in BAT cells. Thus, to evidence that miR-155 and C/EBPβ 
may form a novel bio-stability in the regulation of brown adipocyte differentiation, the further 
experiments were performed.  
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Such feedback loops are important in developmental transcriptional regulation and are known to 
exhibit a bistable behavior (Flynt and Lai, 2008). 
 
3.5.2 miR-155 and C/EBPβ form a negative feed-back loop which regulates brown 
adipocyte proliferation versus differentiation 
To further analyze whether miR-155 and C/EBPβ form a feed-back loop and regulate each other 
in a direct, dose-dependent manner, preadipocytes were infected with increasing amounts of 
lentiviruses either expressing miR-155 or C/EBPβ. Stepwise increase in miR-155 levels (Figure 
36A) resulted in a dose-dependent reduction of C/EBPβ (Figure 36B). On the other hand, 
increasing the abundance of C/EBPβ to levels observed after induction of brown fat 
differentiation with adipogenic hormones resulted in a dose-dependent reduction of miR-155 
(Figure 36C, D).  
                     
Figure 36. (A) qRT-PCR analysis of miR-155 expression levels in preadipocytes transduced with 
LVmiRctrl or different amounts of LVmiR155. Data are normalized to sno202 expression, untreated cells 
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were set as one; data are presented as means ± SEM (***p < 0.001; n=3). (B) Western-blot analysis of 
C/EBPβ protein levels in preadipocytes 48 h post transduction with LVmiRctrl or LVmiR155 (top). 
Quantification of C/EBPβ protein levels (bottom). Data were normalized to Tubulin; untreated cells were 
set as one; data are presented as means ± SEM (*p < 0.05; **p < 0.01; ***p < 0.001; n=3). (C) qRT-PCR 
analysis of C/EBPβ mRNA levels in preadipocytes transduced with LVcontrol or LVC/EBPβ as indicated, 
or stimulated with induction medium (IM) for 8 h  Expression was normalized to HPRT; untransduced 
cells were set as one; data are presented as means ± SEM (***p < 0.001; n=3). (D) qRT-PCR analysis of 
miR-155 expression levels in preadipocytes transduced with LVcontrol or LVC/EBPβ. miR-155 levels 
were normalized to snoRNA202; untransduced cells were set as one. Data are presented as means ± SEM 
(*p < 0.05; n=3). 
 
To better understand the relevance of this reciprocal inhibition, we analyzed the influence of 
miR-155 and C/EBPβ on the differentiation state of brown fat cells. miR-155 overexpression 
correlated with decreased cellular TG content and enhanced proliferation in BAT cells (Figure 
37A). In contrast, C/EBPβ overexpression had the opposite effects resulting in strongly increased 
TG levels and significant reduction of proliferation (Figure 37B). In both approaches, TG levels 
and proliferation rates were regulated in a clearly LVmiR155/ LV/CEBPβ dose-dependent 
manner. 
               
Figure 37. TG content and cell number of brown adipocytes transduced with different doses of (A) 
LVmiR155 (0 ng, 62.5 ng, 250 ng, 500 ng RTase/well in 6-well plates) or (B) LVC/EBPβ (0 ng, 50 ng, 
200 ng, 400 ng RTase/well in 6-well plates). TG content was normalized to total protein concentration. 
LVmiRctrl transduced cells were set as one. All data are represented as means ± SEM. (#p <0.05; n=3 in 
TG assay, *p <0.05; n=3 in proliferation assay). 
 
Preadipocyte factor 1 (Pref-1), a trans-membrane protein highly expressed in undifferentiated 
preadipocytes (Wang and Sul, 2009), was highly expressed in miR-155 overexpressing cells 
(Figure 38A, B). In contrast, cells with low miR-155 (Figure 38A) or high C/EBPβ levels 
(Figure 38B) displayed strongly reduced Pref-1 abundance.  
A B 
Results 
73 
 
                      
Figure 38. Western-blot analysis of Pref-1 expression in preadipocytes transduced with (A) LVmiRctrl 
and LVmiR-155 or (B) LVcontrol and LVC/EBPβ at different dosages. Tubulin served as loading control. 
 
Taken all these data together, these data indicate that miR-155 and C/EBPβ constitute a bistable 
system/loop that either maintains preadipocytes in a proliferative, undifferentiated stem cell state 
or initiates the brown adipogenic differentiation and thermogenesis program. 
 
3.6 miR-155 inhibits brown fat differentiation in vivo 
To study the function of miR-155 in vivo, we generated transgenic mice overexpressing miR-155 
under control of the ubiquitous phosphoglycerate kinase (PGK) promoter (miR155TG) (Figure 
39) using lentiviral transgenesis (Lois et al., 2002; Pfeifer et al., 2002). 
                                            
                                                     
Figure 39. (A) Schematic representation of the lentiviral construct (LVPGK-miR-155) used for 
generation of miR-155 transgenic animals. LTR, long terminal repeat; cPPT, central polypurine tract; 
PGK, phosphoglycerate 1 promoter; GFP, green fluorescent protein; pre-miR155, precursor miR-155; 
WPRE, woodchuck hepatitis responsive element; triangle, self-inactivating mutation. (B) miR-155 
transgenic embryos mixed with wt embryos were transplanted (ET) to foster mice (C) qRT-PCR analysis 
of miR-155 expression levels in the interscapular brown adipose tissue (BAT) from one week old wt or 
miR-155 transgenic (miR155TG) mice, generated by transduction of preimplantation embryos with 
LVPGK-miR-155. miR-155 levels were normalized to snoRNA202. Data of wt were set as one; data are 
represented as means ± SEM (***P < 0.001, n=3). 
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One week old miR155TG animals displayed significantly reduced size and weight of BAT 
compared to their wt littermates (Figure 40A, B). Hematoxylin and eosin (H&E) staining on BAT 
revealed that the size and number of lipid droplets in interscapular BAT of miR155TG were 
clearly reduced, similar to the in vitro situation (Figure 40C). This finding corresponded with a 
significantly reduced TG content (Figure 40D) and reduced expression of the key adipogenic and 
thermogenic factors (Figure 40E, F).  
                           
                                    
Figure 40. (A) Interscapular brown adipose tissue isolated from one week old wt or LVPGKmiR155 
transgenic mice. Shown are bright field (left) and fluorescent images (right); GFP is co-expressed with 
miR-155 in transgenic mice; (scale bar = 2 mm). (B) Ratios of interscapular BAT and liver weight to total 
body weight of one week old wt and miR155TG mice. Data are presented as means ± SEM (***P < 0.001; 
ns: not significant; wt group n=6, miR155TG group n=6). (C) Hematoxylin and eosin staining of BAT 
sections from one week old wt and miR-155TG littermates; (scale bar, 15 µm). (D) TG content of 
interscapular BAT isolated from one week old wt or miR155TG mice. TG content was normalized to total 
protein concentration of lysates. wt was set as one, and data are represented as means ± SEM (*p 
<0.05;**p <0.01 n=3). (E) Western Blot analysis of UCP1, PGC-1α, PPAR and C/EBPβ expression in 
BAT isolated from one week old wt and miR-155TG littermates; each protein levels from three 
representative animals per group are shown. Tubulin served as loading control. (F) Densitometric 
quantification of UCP1, PGC-1α, PPAR and C/EBPβ expression levels, normalized to tubulin. Data of 
the wt group were set as one. Data are represented as means ± SEM (*p <0.05; n=6). 
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Remarkably, miR155TG mice displayed a significant reduction of BAT–derived thermogenesis 
as measured by infrared thermography (Haas et al., 2009; Hodges et al., 2008). Interscapular 
surface temperature of one week old pups was 1.5°C± 0.9°C lower in miR155TG mice compared 
to wt animals (Figure 41 A, B). 
  
                          
Figure 41. (A) Infrared thermographic analysis of the body surface temperature in four day old wt and 
miR155TG littermates. Three representative pairs are shown. (B) Statistical analysis of body surface 
temperature in wt and miR155TG littermates; wt: 34.75±0.39°C; miR155TG: 33.24±0.53°C. Data are 
represented as means ± SEM. (*p <0.05; n=5). 
 
Also at 10 weeks of age, miR155TG mice exhibited a significantly reduced interscapular BAT 
mass and clearly lower levels of thermogenic markers in BAT. In contrast, size and weight of 
inguinal WAT and visceral WAT were not affected by miR-155 overexpression (Figure 42A, B, 
C), albeit similar levels of miR-155 expression were reached in WAT and BAT (Figure 42D, E). 
miR155TG animals do not show significant alterations in body weight or food intake (Figure 
42F, G). These data indicate a preferential effect of miR-155 on BAT development, which is 
reminiscent of the alterations observed in C/EBPβ-deficient mice (Tanaka et al., 1997). 
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Figure 42. (A) Interscapular brown adipose tissue (BAT) (scale bar = 3 mm), inguinal white adipose 
tissue (igWAT), and visceral white adipose tissue (vWAT) (Scale bar = 4 mm) were isolated from ten 
week old wt or miR155TG littermates. Two representative littermates are shown. (B) Statistics of BAT, 
igWAT, vWAT, spleen, heart, brain and liver weights relative to total body weight in ten week old wt and 
miR155TG littermates. Data are presented as means ± SEM (*p <0.05; **p <0.01; n.s., not significant; wt 
group n=3, miR155TG group n=3). (C) qRT-PCR analysis of brown thermogenic/adipogenic genes in 
interscapular BAT of wt or miR155TG littermates at ten weeks of age: UCP1, PGC-1α, PPARγ. Data are 
presented as means ± SEM (*p <0.05; **p <0.01; n.s., not significant; wt group n=3, miR155TG group 
n=3). (D, E) qRT-PCR analysis of miR-155 expression levels in (D) interscapular BAT, or in (E) igWAT 
from ten week old wt or miR155TG mice. miR-155 levels were normalized to snoRNA202. wt was set as 
one; data are represented as means ± SEM (*p <0.05;**p <0.01 n=3). (F) Body weight and (G) daily food 
intake of wt and miR155TG littermates at 10-13 weeks of age (wt group n=5, miR155TG group n=9). 
 
To study whether the observed phenotype in BAT is cell-autonomous, we generated an 
additional, BAT-specific mouse model using the UCP1 promoter to drive miR-155 expression 
(LVUCP1miR155) (Figure 43A). Transduction of brown preadipocytes with LVUCP1miR155 
clearly reduced in vitro differentiation demonstrating the functionality of the UCP1-miR-155 
construct in brown fat cells (Figure 43B). One week old LVUCP1miR155 transgenic animals 
(Figure 43C), showed a phenotype very similar to the miR155TG mice with ubiquitous miR-155 
expression: Body surface temperature and BAT weight were significantly decreased (Figure 43D, 
E). In addition, size and number of lipid droplets in BAT (Figure 43F), as well as expression of 
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PPAR and UCP1 were clearly reduced (Figure 43G, H). Thus, both transgenic animal models 
demonstrate that miR-155 overexpression in vivo impairs BAT function. 
 
Figure 43. (A) Schematic representation of the lentiviral construct (LVUCP1miR155) for brown fat-
specific expression of miR-155. LTR, long terminal repeat; cPPT, central polypurine tract; UCP1, 
uncoupling protein 1 promoter; GFP, green fluorescent protein; pre-miR-155, precursor miR-155; WPRE, 
woodchuck hepatitis responsive element; triangle, self-inactivating mutation. (B) Oil Red O staining of 
differentiated brown adipocytes transduced with LVUCP1-miR-155 as compared to wt cells. (C) qRT-
PCR analysis of miR-155 expression levels in one week old wt and miR-155 transgenic 
(LVUCP1miR155TG) mice generated by transduction of preimplantation embryos with LVUCP1miR155. 
miR-155 levels were normalized to snoRNA202. Data are represented as means ± SEM. (***p < 0.001; 
wt group n=7, LVUCP1miR155TG group n=7). (D) Body surface temperature of wt and 
LVUCP1miR155TG mice was measured by infrared thermography. (E) Ratios of BAT and liver weight 
versus total body weight. Data are represented as means ± SEM. (*p < 0.05; n.s., not significant; wt group 
n=7, LVUCP1miR155TG group n=7). (F) Hematoxylin and eosin staining of BAT sections from one 
week old wt and LVUCP1miR155TG littermates; (scale bar, 15 µm). (G) Western Blot analysis of UCP1 
and PPARγ protein levels in BAT isolated from wt and LVUCP1miR155TG littermates. Tubulin served 
as loading control. 2 representative pairs are shown. (H) Densitometric quantification of Western blot 
analysis (right). Proteins expression was normalized to Tubulin. Data are presented as means ± SEM. (*p 
< 0.05; wt group n=7, LVUCP1miR155TG group n=7). 
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3.7 Role of miR-155 in white adipocytes 
3.7.1 miR-155 regulates white adipocyte “browning” in vitro 
To assess the effects of miR-155 on white fat cells, we isolated SVF cells from murine inguinal 
WAT of 10-12 weeks old wt male mice and overexpressed miR-155 using three different 
concentrations of LVmiR155 (60, 180 and 500 ng RTase per well in 6 well-plates). In addition, 
we knocked-down miR-155 with the “sponge” construct and used siC/EBPβ to analyze directly 
the effect of C/EBPβ. Overexpression of miR-155 at high levels (500 ng RTase) (Figure 44A) 
significantly reduced lipid-droplet accumulation, TG-content (Figure 44B, C), and adipogenic 
marker (aP2, PPARγ, and C/EBPα) levels in white adipocytes (Figure 44D), whereas 
transduction with LVmiRS155 resulted in enhanced differentiation (Figure 44A-D). Interestingly, 
we not only found regular adipogenic markers, but also thermogenic markers regulated by miR-
155: UCP1, the major brown fat specific marker, was strongly enhanced by knock-down of miR-
155 even in WAT cells (Figure 44E). Therefore, we proceeded to study the crucial role of miR-
155 in WAT cells and its possible role in “browning”.  
                              
     
Figure 44. (A) qRT-PCR analysis of miR-155 expression levels in LVmiRctrl, LVmiR155 or 
LVmiRS155 transduced white preadipocytes (normalized to snoRNA202). Untransduced cells (mock) 
were set as one. Data are represented as means ± SEM (***p <0.001; n=3). (B) Oil Red O staining of 
fully differentiated white adipocytes (WAT) overexpressing miR-155 (LVmiR155) or an anti-miR-155 
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sponge (LVmiRS155) as compared to cells carrying a control scrambled miRNA (LVmiRctrl); mock, 
uninfected cells. (C) TG content of fully differentiated white adipocytes transduced with LVmiRctrl, 
LVmiR155, and LVmiRS155; mock, uninfected control. TG content was normalized to total protein 
concentration. Untreated cells were set as one. Data are represented as means ± SEM. (*p <0.05; ***p 
<0.001; n=3). (D) qRT-PCR analysis of aP2, C/EBPα, and PPARγ mRNA in fully differentiated white 
adipocytes transduced with indicated lentiviruses.  Untreated cells were set as one. Data are presented as 
mean±SEM (*p <0.05; n=3). (E) Western Blot analysis of UCP1 protein levels in LVmiRctrl, LVmiR155 
or LVmiRS155 transduced fully differentiated white adipocytes at day 9. Tubulin served as loading 
control.  
 
Given the prominent effect of miR-155 on the development of the thermogenic program in 
brown adipocytes, we examined whether miR-155 might also have similar effects in WAT 
progenitors. Importantly, inhibition of endogenous miR-155 dramatically induced expression of 
UCP1 more than 20-fold (Figure 45). Remarkably, the increase in UCP1 expression induced by 
the miR-155 sponge was even higher than the effect of norepinephrine (NE), a well-known 
inducer of "browning" (Cinti, 2009), and was identical to the effect of C/EBPβ overexpression 
(Figure 44). PGC-1α and Cidea were almost undetectable in mature WAT cells; however, both 
were significantly increased by knock-down of miR-155. In contrast, transduction with 
LVmiR155 further decreased the already low expression levels of UCP1 in mature WAT cells 
(Figure 45). 
                   
Figure 45. qRT-PCR analysis of UCP1, PGC-1α and Cidea mRNA levels in differentiated white 
adipocytes transduced with LVC/EBPβ, LVmiR155, LVmiRS155, LVmiRctrl or treated with 5 μM 
norepinephrine (NE). Differentiated BAT cells were used as positive control. Untreated white fat cells 
were set as one. Data were normalized to HPRT housekeeping gene expression and are represented as 
means ± SEM. (*p <0.05; **p <0.01; ***p <0.001; n=3).  
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3.7.2 miR-155 and C/EBPβ are specific regulators in brown adipocyte differentiation 
To address the question, whether the miR-155/C/EBPβ circuit is of general relevance for both 
brown and white fat differentiation, or if this interaction is rather specific for brown fat, we 
performed also transduction experiments at low- and medium-dose of LVmiR155 in BAT and 
WAT-derived adipocytes (Figure 46A-D). In parallel, we performed low- and medium-dose 
knock-down experiments with LVsiC/EBPβ, as well as LVmiRS155.  
 
Figure 46. (A, B) Oil Red O staining (A) and qRT-PCR analysis (B) of UCP1, PGC-1α, Cidea, PPARγ, 
C/EBPα, and aP2 mRNA of brown adipocytes transduced with a low (60 ng) or medium (180 ng) dosage 
of control-miR (LVmiRctrl), miR-155 (LVmiR155) or anti-C/EBPβ siRNA (siC/EBPβ), or low dosage of 
anti-miR-155 sponge (LVmiRS155); mock, uninfected cells. Uninfected cells were set as one. Expression 
data are normalized to HPRT, and data are represented as means± SEM. (*p <0.05; n=3). (C, D) Oil Red 
O staining (C) and qRT-PCR analysis (D) of UCP1, PGC-1α, Cidea, PPARγ, C/EBPα, and aP2 mRNA 
of white adipocytes transduced with with a low (60 ng) or medium (180 ng) dosage of control-miR 
(LVmiRctrl), miR-155 (LVmiR155) or anti-C/EBPβ siRNA (siC/EBPβ), or low dosage of anti-miR-155 
sponge (LVmiRS155); mock, uninfected cells. Uninfected cells were set as one. Expression data are 
normalized to HPRT, and data are represented as means± SEM. (*p <0.05; n=3). 
 
In brown fat cells, we found a significant inhibition of differentiation already at the low dose (60 
ng) of miR-155 with a 28% decrease in expression of PPARγ and reduced Oil Red O staining. 
The thermogenic program (as determined by measurement of UCP1, PGC-1α and Cidea levels) 
was also significantly suppressed by low levels of miR-155 (Figure 46A, B). In contrast, the low 
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concentration of miR-155 had no significant effect on any of the marker genes tested during 
white fat cell differentiation (Figure 46C, D). Accordingly, knock-down of C/EBPβ had a 
stronger striking impact on marker expression in brown versus white fat cells. The low 
concentration of siC/EBPβ reduced adipogenic as well as thermogenic markers by 83.7 to 98.9% 
in brown adipocytes, but had no significant effect in white adipocytes (Figure 46A-D). 
The medium dose (180 ng) of miR-155 caused a significant reduction of the thermogenic marker 
gene expression, but was still not sufficient to significantly affect all adipogenic markers in white 
fat cells. siC/EBPβ significantly inhibited white adipocyte differentiation at medium 
concentrations (maximum suppression 55.6-60.1% at 180ng) (Figure 46D). The effects of 
medium dose siC/EBPβ were much more pronounced in brown fat cells resulting in a 87.1 to 
99.3% reduction of marker gene expression (Figure 46B). All these data point towards higher 
sensitivity of brown adipocytes for miR-155- and C/EBPβ-dependent regulation and a 
predominant role of the miR-155/C/EBPβ interaction in brown fat.  
Moreover, knocking-down miR-155 with low-dose sponge lentivirus, LVmiRS155, still 
enhanced thermogenic genes (UCP1, PGC-1α and Cidea) in brown adipocytes. Importantly, 
these thermogenic genes were also highly increased in low-dose LVmiRS155 treated white 
adipocytes. 
Thus, taken all together, the data demonstrate that the miR-155/C/EBPβ regulatory feedback 
loop has a specific effect in brown adipocytes. Furthermore, knock-down of miR-155 reprograms 
white adipocytes to brown fat-like adipocytes which effect is similar to the C/EBPβ effect in the 
white fat cell line HIB-1B (Karamanlidis et al., 2007). 
 
3.8 miR-155 regulates cold-induced thermogenesis in adipose tissue and “browning” of 
WAT in vivo 
To analyze the effect of miR-155 suppression on WAT browning and BAT recruitment in vivo, 
we used Bic/miR-155 knock-out (miR-155
-/-
) mice (Thai et al., 2007). BAT activation was 
studied by exposing mice to cold (4°C, 4 h). BAT activity and interscapular body surface 
temperature was analyzed using infrared thermography, and core body temperature was 
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measured with a 4610 rectal thermometer. Interscapular temperature of miR-155
-/-
 mice was 
significantly higher (38.4°C ± 0.66°C) as compared to the wt littermates (35°C ± 0.37°C) after 
cold exposure indicating that inducible thermogenesis of BAT is significantly increased in the 
absence of miR-155 (Figure 47A, B).  
In addition, analysis of body core temperature revealed a significant difference between miR-
155
-/- 
and wt mice already at room temperature. After 4 h cold exposure, core temperature 
dropped by 3 ± 0.39 °C in wt but only 0.8 ± 0.3 °C in miR-155
-/- 
mice (Figure 47C). 
          
Figure 47. (A) Representative infrared thermographic image of 12-16 week old male wt and miR-155
-/-
 
littermates kept at 4°C for 4 h. (B) Statistical analysis of body surface temperature as measured by 
infrared thermography. Data are represented as means ± SEM. (*p <0.05; n.s., not significant; wt group 
n=7, miR-155
-/-
 group n=5). (C) Statistical analysis of rectal body core temperature measurement of 12-
16 weeks old wt, or miR-155
-/-
 littermates exposed to either RT or 4 °C. Data are represented as means ± 
SEM (*p <0.05; ***p <0.001) (wt group n=14, miR-155
-/-
 group n=12). 
 
For a more detailed analysis, the animals were sacrificed and the organs and tissues were isolated. 
Analysis of BAT morphology revealed fewer lipid droplets in miR-155
-/-
 mice after 4 °C 
treatment (Figure 48A). Exposure to cold increased lipolytic activity and cellular respiration to a 
greater extent in miR-155
-/-
 mice than in wt mice (Figure 48B, C), which could explain the 
reduced lipid content of miR-155
-/-
 BAT. Moreover, miR-155
-/-
 mice exhibited increased 
expression of UCP1 and PGC-1a (Figure 48D). 
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Figure 48. (A) Hematoxylin and eosin staining of interscapular BAT sections from wt and miR-155
-/-
 
littermates kept at room temperature (RT) or post cold exposure (4 °C, 4 h) (scale bar, 50 µm). (B) 
Lipolysis assay of BAT from 12 week old wt and miR-155
-/-
 littermates kept in 4 °C for 4 h (*p <0.05; 
n=4). (C) Ex vivo Oxygraph measurement of cellular mitochondrial respiration in BAT from 12 to 16 
weeks old wt or miR-155
-/-
 littermates exposed to 4 °C (*P<0.05; wt group n=6, miR-155
-/-
 group n=5). 
(D) qRT-PCR analysis of UCP1 and PGC-1α expression in BAT of 12 to 16 week old wt or miR-155-/- 
littermates after cold exposure (*P<0.05; n=4). 
 
Given the impact of miR-155 on the development of a brown fat-like thermogenic program in 
white adipocytes (Figure 45 and Fig. 46C, D), we studied whether cold-induced WAT browning 
is affected by loss of miR-155 in vivo. igWAT of miR-155
-/-
 mice kept at ambient temperature 
was clearly morphologically different from wt mice (Figure 49A). miR-155
-/- 
igWAT contained 
clusters of adipocytes with brown adipocyte-like multilocular lipid droplets (Figure 49A). After 
cold exposure, the induction of a brown fat phenotype in WAT was clearly enhanced in miR-
155
-/-
 mice. Exposure to cold for only 4 h resulted in the predominance of small adipocytes with 
multilocular lipid droplets in the igWAT of miR155
-/- 
mice. Furthermore, we found a stronger 
induction of UCP1 and PGC-1a expression, and enhanced cellular respiration in miR155
-/- 
mice 
compared to wt littermates (Figure 49B, C). Body weight of 12-16 week old miR-155
-/-
 mice was 
significantly lower, whereas food intake of these animals was not altered when compared to wt 
littermates (Figure 49D, E). 
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Figure 49. (A) Representative hematoxylin and eosin staining of igWAT sections from wt and miR-155
-/-
 
littermates at room temperature or post cold exposure (top). Immunohistochemical staining for UCP1 
abundance in respective igWAT sections (bottom) (scale bar, 50 µm). (B) Ex vivo Oxygraph 
measurement of cellular mitochondrial respiration in igWAT of wt and miR-155
-/-
 littermates at 12 to 16 
weeks of age (*P<0.05; wt group n=6, miR-155
-/-
 group n=5). (C) qRT-PCR analysis of UCP1 and PGC-
1α in igWAT from 12 to 16 week old wt or miR-155-/- littermates exposed to 4 °C for 4 h (*P<0.05; wt 
group n=4, miR-155
-/-
 group n=4). (D) Body weight and (E) daily food intake of wt and miR-155
-/-
 
littermates at 12-16 weeks of age. Data are represented as means ± SEM (**P<0.01; wt group n=12, miR-
155
-/-
 group n=16). 
 
Importantly, we found that even heterozygous miR-155 (miR-155
+/-
) mice that express about 
50% less miR-155 than wt mice (Figure 50A) presented an altered phenotype with significantly 
enhanced thermogenesis and cellular respiration (Figure 50B-E). Ex vivo respiration rates of 
miR-155
+/-
 BAT and igWAT were significantly increased but did not reach levels as high as in 
miR-155
-/-
 animals (Figure 50E, F). These findings show that changes of miR-155 – even at 
moderate levels - induce activation of the thermogenic program in brown and white adipose 
tissue depots. 
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Figure 50. (A) RT-PCR analysis of miR-155 expression levels in interscapular brown adipose tissue 
(BAT) from 16 week old mice. Data are normalized to sno202RNA expression; data of wt group were set 
as one; data are represented as means ± SEM (**P<0.01; *** P<0.001; wt group n=3, miR-155
+/-
 group 
n=3, and miR-155
-/-
 group n=3). (B) Infrared thermography analysis of body surface temperature of 12-16 
week old wt, miR-155
+/-
 or miR-155
-/-
 littermates exposed to 4 °C. (C) Statistical analysis of body surface 
temperature. Data are represented as means ± SEM (*P<0.05; n.s., not significant) (wt group n=7, miR-
155
+/-
 group n=5, and miR-155
-/-
 group n=5). (D) Statistical analysis of rectal body core temperature 
measurement of 12-16 week old wt, miR-155
+/-
 or miR-155
-/-
 littermates exposed to either RT or 4 °C. 
Data are represented as means ± SEM (*P<0.05; *** P<0.001; n.s., not significant) (wt group n=14, miR-
155
+/-
 group n=14, and miR-155
-/-
 group n=12). (E, F) Ex vivo Oxygraph measurement of cellular 
mitochondrial respiration in (E) interscapular BAT, or in (F) igWAT of wt, miR-155
+/-
 and miR-155
-/-
 
littermates at 12-16 weeks of age. Data are represented as means ± SEM (*P<0.05; **P<0.01; 
***P<0.001; n.s., not significant; wt group n=6, miR-155
+/-
 group n=6, and miR-155
-/- 
group n=5). 
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4. Discussion 
4.1. miR-155 works as inhibitor of brown adipose tissue 
The recent findings of metabolically active BAT in adults (Enerback, 2010; Nedergaard and 
Cannon, 2010) considerably raised the interest in brown fat cell development. Brown adipocytes 
of the "classical" interscapular BAT depot originate from Myf5-positive progenitors (Kajimura 
et al., 2010). In addition, beige cells with multilocular morphology and UCP1 expression have 
been described in WAT that are not derived from Myf5-positive precursor cells (Petrovic et al., 
2010). The development of these beige cells is induced by cold-exposure or β3-agonists (Seale et 
al., 2008), such as NE (norepinephrine). Apart from these factors several other stimuli have been 
described that enhance recruitment of beige cells including prostaglandins, the transcription 
factor FOXC2 and PPARγ agonists (thiazolidinediones) (Cinti, 2009; Yang et al., 2003), as well 
as natriuretic peptides and cGMP (Bordicchia et al., 2012; Jennissen et al., 2012). So far not 
much was known about miRNA-based regulation of brown and beige adipocytes.  
miRNAs control the expression of a large part of the human and murine genome. Up to 30% of 
the human genes are regulated by miRNAs, thereby modulating diverse biological cellular 
processes. Initial studies revealed differential expression of miRNAs in white and brown 
adipocytes and that muscle-specific miRNAs are expressed in brown adipocytes (Walden et al., 
2009). A recent study by (Sun et al., 2011) found that the miR193b-365 cluster enhances brown 
adipogenesis of mesenchymal progenitors mainly by suppression of myogenic genes during in 
vitro differentiation.  
Using a genome-wide deep sequencing approach, I identified miRNAs that are differentially 
expressed in brown adipocyte differentiation in vitro. Among the miRNAs enriched in 
preadipocytes, miR-155 was of special interest as it efficiently inhibited adipogenesis, was 
strongly reduced in mature brown fat cells and was enriched in brown adipose tissue as 
compared to white adipose tissue. 
miR-155 has been shown to regulate gene expression in the hematopoietic system, such as B-
cells, T-cells, macrophages as well as immune response cells or cancer cells (O'Connell et al., 
2010). In our study, we demonstrate that miR-155 has a significant inhibitory effect in fat tissue, 
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especially in brown adipose tissue. miR-155 is able to inhibit brown fat differentiation, as well as 
thermogenic function of brown fat cells. Thus, miR-155 was to the best of our knowledge the 
first miRNA inhibitor of brown fat adipogenesis until miR-133a has been shown that it is another 
miRNA inhibitor (Trajkovski et al., 2012a). Similar to the situation in cancer, where oncogenic 
miRNAs that promote tumor formation or growth and tumor-suppressive, anti-oncogenic 
miRNAs have been identified (Pfeifer and Lehmann, 2010), we propose that an interplay of 
“pro-adipogenic” miRNAs – such as miR-193b-365 (Sun et al., 2011) and “anti-adipogenic” 
miRNAs like miR-155 orchestrates brown fat differentiation.  
 
4.2. miR-155 targets C/EBPβ, the crucial transcriptional factor in brown adipose 
differentiation 
Brown and white differentiation processes share many transcriptional regulators (Seale et al., 
2007). For example, PPARγ has been clearly identified as a master regulator of both white and 
brown adipogenesis and the interplay between PPARγ and members of the C/EBP family are 
critical for general adipocyte development. However, the effects of PPARγ and of individual 
members of the C/EBP family are not identical and there appears to be a specificity of certain 
C/EBPs for white versus brown fat. C/EBPα is required for differentiation of white, but not 
brown, adipose tissue (Linhart et al., 2001). The analysis of C/EBPβ and C/EBPβ/C/EBPδ 
knockout mice revealed a predominant role of C/EBPβ in BAT (Tanaka et al., 1997) with only 
little effect of C/EBPβ-deficiency on white adipocyte development and function. 
But how can C/EBPβ be essential for establishment of a brown fat phenotype when it has been 
demonstrated that it can also initiate the adipogenic differentiation program in white adipose 
precursors? This puzzle might be explained by (i) differences in the temporal dynamics of 
C/EBPβ expression in brown versus white cells, with sustained C/EBPβ exposure resulting in the 
brown phenotype (Karamanlidis et al., 2007) and / or (ii) by its interaction with the 
transcriptional coregulator PRDM16. PRDM16 and C/EBPβ are co-enriched in BAT and form a 
transcriptional complex that controls the cell fate switch to brown fat cells (Kajimura et al., 2009; 
Seale et al., 2008). In the context of overexpression of C/EBP alone induces a brown fat cell-
like phenotype in white adipocytes (Karamanlidis et al., 2007). 
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C/EBP, the crucial pro-adipogenic transcription factor, had been identified as a major miR-155 
target in other cell types including white preadipocytes (He et al., 2009; Skarn et al., 2011; 
Worm et al., 2009).  Its 3’UTR contains one conserved 8mer miR-155 “seed” binding site 
(www.targetscan.org). Interestingly, in our study we found that miR-155 also efficiently 
inhibited C/EBP expression in brown preadipocytes. miR-155 transduced brown adipocytes 
revealed reduced protein levels of all three C/EPBβ isoforms: LAP, LAP*, and LIP. Both LAPs 
have been shown to be important in BAT cell differentiation (Nerlov, 2007). Transduction of 
miR-155 in BAT cells with lentiviral vectors carrying C/EBP restored LAP protein levels. This 
C/EBP restorage rescued brown fat cell differentiation back to the wild type situation. It 
demonstrates that C/EBP is the major target of miR-155 in brown fat precursor cells.  
Moreover, luciferase reporter assays have shown that miR-155 directly binds to the C/EBP 
mRNA 3’UTR which is shared by all three C/EBP isoforms, resulting in reduced reporter 
activity. Mutating the putative miR-155 8mer binding site in the 3’UTR of C/EBP rescued the 
reduced reporter activity back to wild type control levels. 
An intricate network of regulators controls C/EBP expression and function. Among these are 
adipogenic hormones like insulin, transcription factors (e.g. CREB, Plac8, Forkhead TFs and 
HOXC8), as well as post-transcriptional regulators (e.g. KSR1 and TRB3) (Bezy et al., 2007; 
Jimenez-Preitner et al., 2011; Kortum et al., 2005; Mori et al., 2012; Seale et al., 2009). miR-
155-based post-transcriptional regulation of C/EBP adds another level of regulation. miR-155 
shows an interesting temporal expression pattern with high levels during preadipocyte 
proliferation and mitotic clonal expansion (MCE), but decreasing expression during maturation. 
The expression changes of miR-155 during brown fat differentiation highlights its decisive 
function in the temporal regulation of C/EBPβ which expresses at low level during proliferation 
or MCE stage of preadipocytes, and is increasing during the differentiation. Similar regulatory 
patterns have been described for Plac8-dependent regulation of C/EBP expression (Jimenez-
Preitner et al., 2011). Therefore, the correct timing of C/EBP expression is crucial for 
adipogenic differentiation. 
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4.3. miR-155 expression is regulated by the TGFβ1 signaling pathway in BAT 
The transcription factor TGFβ1 was shown to positively regulate miR-155 via the TGFβ/Smad 
pathway in epithelial cells (Kong et al., 2008). Furthermore, TGFβ has been shown to potently 
inhibit adipogenesis in 3T3L1 cells (Choy et al., 2000; Ignotz and Massague, 1985). Therefore, 
we tested whether TGFβ1 is involved in the regulation of miR-155 expression in brown 
adipocytes.  
Remarkably, TGFβ1 expression was regulated in a differentiation-dependent manner very 
similar to miR-155 in the in vitro adipogenesis experiments. Strongest induction of TGFβ1 was 
measured in the confluent/postconfluent phase at day 0, around the time-point of maximal miR-
155 expression. TGFβ1 expression levels decreased significantly after cells had entered 
differentiation phase (day 0-day 4), which indicates that TGFβ1 is not essential at the early stage 
of differentiation in BAT cells.  
In addition, we could show a direct effect of TGFβ1 on miR-155 transcription: Treatment of 
preadipocytes with TGFβ1 (5ng/ml) induced a significant increase in miR-155 levels within 24h. 
When we treated BAT cells with the TGFβ1 receptor inhibitor SB-431542 to block TGFβ1 
signaling, miR-155 levels were strongly reduced, resulting in enhanced BAT cell differentiation. 
Taken together all experimental data, it demonstrates that miR-155 is regulated by TGFβ1 
pathway signaling in preadipocytes. Previous studies have shown transcriptional induction of 
miR-155 by the TGFβ/Smad pathway in epithelial cells (Kong et al., 2008). In brown 
preadipocytes, however, our data also suggest that TGFβ1 regulates miR-155 via Smad4. 
Although TGFβ1 levels are increasing at late stage ofdifferentiation (day 8), miR-155 expression 
remains at low levels in mature brown fat cells. These  results indicate that miR-155 is not only 
regulated by TGFβ1, but also by other miR-155 inhibitory factors which are presumably  
strongly expressed at the late stage of differentiation. Therefore, we sought to identify other 
mechanisms/signals that – apart from TGFβ- are involved in miR-155 regulation.  
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4.4. C/EBPβ and miR-155 form a bistable feedback loop in BAT 
To investigate which factor regulates miR-155 at the stage of BAT cell differentiation, we have 
analyzed the BIC/miR-155 promoter region for relevant transcription factor binding sites. 
Interestingly, we identified 5 putative binding sites for transcription factors of the C/EBP family 
which are essential transcription factors in BAT cell differentiation. The experimental results 
demonstrated that all C/EBPs are able to repress the BIC/miR-155 promoter activity via binding 
to the BIC/miR-155 promoter. Among the C/EBPs, C/EBPβ reduced the activity most strongly 
and can therefore be considered the most prominent regulator of BIC/ miR-155 transcription in 
brown adipocytes. 
Thus, importantly, we found a reciprocal negative regulation or double negative feedback loop 
(Figure 51) between miR-155 and C/EBP that integrates pro- and anti-adipogenic cues during 
brown fat cell differentiation. One such anti-adipogenic cue is TGFβ1 which is secreted by 
proliferating precursor cells and induces miR-155 expression. High levels of miR-155 inhibit 
C/EBP expression, thereby suppressing premature differentiation and keeping preadipocytes in 
an undifferentiated proliferative state. Pro-adipogenic hormones induce expression of C/EBP, 
which in turn inhibits transcription of BIC/miR-155. Thus, this double negative feedback 
mechanism leads to robust commitment to one of two possible states establishing a bistable 
system (Flynt and Lai, 2008). A similar bistable system has been described for the developing 
Drosophila eye (Li and Carthew, 2005) where miR-7 inhibits the transcription factor Yan, which 
in turn represses miR-7 transcription. The miR-155/C/EBP bistable loop might have evolved to 
convert weak or only transiently available external signals to a strong response ensuring a 
uniform response of precursor cells to signals that either prohibit or induce adipogenesis. 
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Figure 51. miR-155 and C/EBPβ form a self-inhibitory feedback loop that tightly regulates brown 
adipogenesis. miR-155 expression is induced by TGFβ1 signaling and mediates translational repression of 
C/EBPβ by binding to its 3´UTR. In turn, C/EBPβ is induced by adipogenic hormones and inhibits 
transcription of miR-155. Thereby, miR-155 and C/EBPβ constitute a bistable system for the regulation 
of adipogenesis and thermogenesis by either maintaining preadipocytes in an undifferentiated precursor 
state (mitotic clonal expansion) or initiating the brown adipogenic program. 
 
4.5. miR-155 regulates brown fat differentiation in vivo 
To gain further insight into the function of miR-155, we transduced preimplantation embryos 
with miR-155 carrying lentivirus to generate miR-155 transgenic mice (Pfeifer et al., 2002). 
These transgenic animals showed reduced BAT mass, altered BAT morphology characterized by 
a strong reduction of lipid droplets and TG content, and significantly reduced UCP1 expression. 
This phenotype corresponds to the impaired differentiation of miR-155 overexpressing 
preadipocytes observed in vitro. Interestingly, the level of miR-155 overexpression achieved in 
the miR155TG mice caused only a slight - albeit significant - reduction of C/EBPβ indicating 
that the major effect of miR-155 transgenesis is not a mere suppression of C/EBPβ but rather a 
destabilization of the miR-155-C/EBPβ feedback loop tipping the balance towards an un-
differentiated state. To measure BAT activation/thermogenesis in vivo, we analyzed the 
interscapular body surface temperature by infrared thermographic imaging as well as body core 
temperature. In line with reduced brown fat differentiation and reduced UCP1 levels, we found 
significantly reduced BAT thermogenesis in miR-155 transgenic mice. In addition, we found a 
significant increase in body core temperature in miR-155 transgenic mice after cold exposure. 
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BAT-specific expression of miR-155 using the UCP1 promoter resulted in the same effects 
indicating that the observed phenotype is cell-autonomous. Thus, miR-155 overexpression leads 
to severe impairment of the thermogenic program and energy expenditure in BAT. Concerning 
the effect of miR-155 on WAT development, the in vitro data show that miR-155 expressed at 
high levels can inhibit differentiation of SVF cells isolated from murine WAT, of human MSCs 
(Skarn et al., 2011) and of 3T3L1 cells (Liu et al., 2011). In contrast to BAT, we found no 
significant changes in WAT weight in the miR-155 transgenic mice, although both tissues 
expressed similar levels of miR-155. Overall, the phenotype of miR-155 transgenics strikingly 
resembles the phenotypic hallmarks of the C/EBP-/- mice (Tanaka et al., 1997).  
 
4.6. miR-155 regulates “browning” of white fat cells 
Most importantly, our study unravels a decisive function of miR-155 in controlling the 
phenotypic switch of white to brown fat-like cells (beige cells): miR-155 depletion activates the 
thermogenic program in white adipocytes in vitro (Figure 52).  
                   
Figure 52. Scheme of the fate of miR-155 expression decreased or deleted white progenitor cells. 
Brown-specific genes are increased in mature miR-155 knock-down fat cells which were differentiated 
from white progenitor cells. Fat Droplets are shown in yellow, and mitochondria are shown in brown.    
 
Consequently, miR-155
-/- 
mice show an increased ability to adapt to cold exposure and recruit 
inducible brown/beige cells in white fat depots. Thus, miR-155 is a key regulator of brown 
adipocyte identity in brown as well as in white fat, which is tightly linked by a bistable feedback 
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loop system to C/EBPβ. Knock-down or knock-out of miR-155 enhances thermogenic gene 
expression in both BAT and WAT. In contrast, transduction of low or medium dosage LVmiR-
155 had a much stronger effect on thermogenic and adipogenic gene expression in brown 
compared to white adipocytes. Furthermore, thermogenic genes are more sensitive to gain- or 
loss- of miR-155, both in brown and white fat. These data characterize miR-155 as a 
predominantly brown-fat specific regulator of thermogenesis. 
Taken together, miR-155 not only plays a role in differentiation of white adipocytes (Liu et al., 
2011), but also has a key function in the regulation of the thermogenic system. When expression 
of miR-155 is decreased or depleted in white fat progenitors, those progenitors will develop 
towards preadipocytes with an increased thermogenic potential. These white preadipocytes are 
able to differentiate to brown like adipocytes (beige adipocytes). These cells expose similar 
thermogenic functions as brown adipocytes (Ohno et al., 2012; Seale et al., 2008; Seale et al., 
2011; Trajkovski et al., 2012b; Vegiopoulos et al., 2010). 
Concerning a potential role of miR-155 in humans it is of interest that miR-155 expression has 
been associated with adipose tissue dysfunction and obesity (Kloting et al., 2009). Obese T2D 
patients exhibited a strong correlation between increased adipocyte diameter and miR-155 
expression. Furthermore, miR-155 expression is significantly correlated to the number of 
macrophages infiltrating subcutaneous fat depots (Kloting et al., 2009). Adipose tissue 
macrophages in insulin-resistant subjects are known to secrete higher levels of TGFβ. Thus, 
macrophage-derived TGFβ might induce miR-155 expression in adipocytes, thereby inhibiting 
the recruitment of inducible brown/brite cells. Since reduction of miR-155 by 50% in 
haploinsufficient mice already enhances differentiation and recruitment of both beige adipocytes 
and BAT cells, therapeutic attempts to reduce miR-155 might be a promising approach to treat 
obesity in humans. 
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5. Summary 
Brown adipose tissue (BAT) is the primary site of energy expenditure by non-shivering heat and 
plays an important role in the regulation of metabolic balance in human adults. Recent studies 
have shown that the energy-storing white adipose tissue (WAT) is able to switch to a brown-
like/beige phenotype with similar capacities regarding thermogenesis and energy expenditure 
like BAT. This process is called “browning”and is mainly induced by cold exposure.  
MicroRNAs (miRNAs) are non-coding, post-transcriptional regulators of gene expression. Each 
miRNA is predicted to target not only one, but up to hundreds of target genes. Therefore, 
miRNAs are part of a complex regulatory network that tightly regulates expression of ~30% of 
the human proteome. MiRNAs play an important role in white fat cell differentiation and are 
deregulated in obese subjects. In contrast, knowledge about the function of miRNAs in brown 
and beige adipocytes is very limited.  
To identify differentially regulated miRNAs with a decisive function in brown adipogenesis, we 
performed a genome-wide deep sequencing screen comparing preadipocytes of murine BAT 
with in vitro differentiated mature brown fat cells. A selected number of candidate miRNAs were 
validated by qRT-PCR. Optimized lentiviral expression vectors were used to over-express 
miRNAs and perform extensive in vitro analysis.  
The candidate miR-155 is significantly downregulated during brown adipocyte differentiation. 
Overexpression of miR-155 resulted in strong inhibition of in vitro adipocyte differentiation as 
assessed by lipid droplet staining, triglyceride content measurement as well as by measuring the 
abundance of adipogenic (C/EBPα, PPARγ and aP2) and thermogenic (UCP1 and PGC-1α) 
markers. 
miR-155 is induced by TGFβ1 during early adipogenesis and is regulated via the TGFβ1/Smad4 
signaling pathway. Furthermore, we identified a double negative feedback loop in which miR-
155 suppresses the transcription factor C/EBPβ that is essential for early adipogenic commitment. 
Importantly, C/EBP reciprocally represses transcription of miR-155 resulting in a bistable 
system that tightly controls differentiation of brown adipocytes. Besides, I demonstrate that this 
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novel miR-155-C/EBP feedback loop not only regulates the differentiation of brown adipocytes, 
but also the capacity of “browning” in WAT cells.   
In vivo studies with two types of miR-155 overexpressing transgenic mice model, as well as with 
knock-out mice model demonstrated that the miR-155-C/EBPβ bistable system is essential for 
normal brown fat development and function: miR-155 transgenic mice exhibited a strongly 
reduced BAT mass with decreased lipid content, reduced expression of adipogenic and 
thermogenic marker proteins, and impaired energy expenditure. In contrast, WAT mass (igWAT, 
vWAT) of these animals was comparable to wild type mice. These data demonstrate that miR-
155 overexpression in vivo has a rather specific function in BAT development and is affecting 
less white adipose tissue depots. Furthermore, studies in miR-155 deficient mice revealed an 
important role of this miRNA for the “browning” capacity of white adipose tissue. 
Taken together, our results show that miRNAs are important regulators of brown adipocyte 
differentiation: They can either inhibit or promote adipogenesis. miR-155 is a crucial regulator in 
brown adipogenic differentiation. It has been shown to inhibit fat differentiation via a newly 
identified miR-155-C/EBP regulatory feedback loop. Blockage of miR-155 enhances the 
differentiation of BAT and the “browning” capability of white adipocytes, resulting in increased 
energy expenditure. Therefore, therapeutic targeting of miR-155 may be a promising future 
strategy to fight obesity and metabolic diseases in humans. 
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